Publications

  1. Radosevich, James A. and A. Galsky. The Concentration of Selected Cations in Normal and Crown-gall Tumors Obtained from Potato Disc. Plant and Cell Physiol. 20 (1): 185-192, 1979.
  2. Radosevich, James A. and R.E. Wing. Starch-based Ion Exchange Materials in Paper: Preparation and Use in Heavy Metal Removal. Starch. 32:424-429, 1980.
  3. Rosen, S.T., Combs, S., Marder, R., Minna, J., Mulshine, J., Polovina, M., and J.A.  Radosevich. Immunohistochemical Localization of the Immunodominant Differentiation Antigen Lacto-N-Fucopentaose III in Normal Adult and Fetal Tissues Utilizing Monoclonal Antibodies.  Colloquium: Protides of the Biological Fluids.  H. Peeters, Ed., Pergamon Press, Vol. 32, 561-566, 1984.
  4. Rosen, S.T., Lambiase, E.A., Ma, Y., Radosevich, J.A., and A.L. Epstein. Monoclona Antibodies for Tumor Diagnosis, Staging and Therapy. Postgraduate Medicine. 77:129-134, 1985.
  5. Rosen, S.T., Goldman-Leikin, R.E., Zimmer, A.M., and J.A. Radosevich. Monoclonal Antibodies in Cancer Therapy.  Laboratory  Medicine, 15:310-314, 1985.
  6. Radosevich, J.A., Ma, Y., Lee, I., Salwen, H.R., Gould, V.E., and S.T. Rosen. Monoclonal Antibody 44-3A6 as a Probe for a Novel Antigen Found Human Lung Carcinomas with glandu differentiation. Cancer Research, 45:5805-5812, 1985.
  7. Lee, I., Radosevich, J.A., Rosen, S.T., Ma, Y., Combs, S.G., and V.E. Gould. Immunohistochemistry of Lung Carcinomas Using Monoclonal Antibody 44-3A6. Cancer Research, 45:5813-5817, 1985.
  8. Banner, B.F., Gould, V.E., Radosevich, J.A., Ma, Y., Lee, I., and S.T. Rosen. Application of Monoclonal Antibody 44-3A6 in the Cytodiagnosis and Classification of Pulmonary Carcinomas.  Diag Cytopathol. 1:300-307, 1985.
  9. Lee, I., Radosevich, J.A., Chejfec, G., Ma, Y., Warren, W.H., Rosen, S.T. and V.E.Gould.  Malignant Mesotheliomas:  Improved Differential Diagnosis From Lung Adenocarcinomas Using Monoclonal Antibodies 44-3A6 and 624A12. American Journal of Pathology. 123:497-507, 1986.
  10. Al-Gailani, F., Marder, R.J., Radosevich, J.A., Hauck, W.W.,  Molteni, A., and S.T.Rosen.  Phase II Trial of Tamoxifen In Lymphocytic Leukemia. Cancer Treatment Reports. 70:1343-1344, 1986.
  11. Winter, J.N., Marder, R.J., Radosevich, J.A. and A.L. Epstein. Monoclonal Antibody DLC-48:  An Effective Reagent For The Use In The Depletion of Malignant Lymphoma From Human Bone Marrow.  Int.J. Cancer. 39:670-677, 1987.
  12. Rosen, S.T., Gould, V.E., Salwen, H.R., LeBeau, M.M., Lee, I., Bauer, K., Marder, R.J., Andersen, R., Kies, M.S., Moll, R., Franke, W.W., and J.A. Radosevich.  Characterization of a Neuroendocrine Skin Carcinoma Cell Line:  In Vitro Comparison With Small Cell Bronchopulmonary Neuroendocrine Carcinomas. Laboratory Investigation. 56:302-312, 1987.
  13. Lee, I., Radosevich, J.A., Ma, Y., Warren, W.H., Rosen, S.T. and  V.E. Gould. Immunohistochemical Analysis of Pulmonary Carcinomas Using Monoclonal Antibody 624-A12.  Path. Res. Pract.  182:40-47, 1987.
  14. Gould, V.E., Widenmann, B., Lee, I., Schwechheimer, K., Dockhorn-Dworniczak, B.,Radosevich, J.A., Moll, R. and W.W. Franke. Synaptophysin Expression in Neuroendocrine Neoplasms as Determined by Immunocytochemistry.  Am. J. Path. 126:243-257, 1987.
  15. Lee, I., Radosevich, J.A., Thor, A., Ma, Y., Schlom, J., Gould, V.E. and S.T. Rosen. Immunohistochemical Detection of ras Oncogene Products In Pulmonary and Pleural Neoplasms.  Virchows Arch.of Pathology.  (B) Cell Biology 53:146-153, 1987.
  16. Shambaugh, G.E., Koehler, R.R. and J.A. Radosevich.  Nutrition and Fetal Brain Maturation.  I. Response In Vitro and In Vivo.  J. Experimental Cell Research.172:404-416, 1987.
  17. Shambaugh, G.E., Koehler, R.R. and J.A. Radosevich.  Nutrition and Fetal Brain Maturation.  II.  The Impact of Maternal Starvation on Changing Levels of Acetylcholinesterase and Enolase In Vitro J. Experimental Cell Research.175:344-353,1988.
  18. Combs, S.G., Radosevich, J.A., Ma, Y., Lee, I., Gould, V.E., Battifora, H., and S.T. Rosen.  Expression of the Antigenic  Determinant Recognized by the Monoclonal Antibody 44-3A6 on Select Human Adenocarcinomas and Normal Human Tissues.Tumor Biology. 9:116-122, 1988.
  19. Piehl, M.R., Gould, V.E., Radosevich, J.A., Ma, Y., Warren, W.H., and S.T. Rosen. Immunohistochemical Identification of Exocrine and Neuroendocrine Subsets of Large Cell Lung Carcinomas. Pathology, Research and Practice. 183:675-682, 1988.
  20. Combs, S.G., Hidvegi, D.F., Ma, Y., Rosen, S.T. and J.A. Radosevich. Pleomorphic Carcinoma of the Pancreas:  A rare case report of combined histological features of pleomorphic adenocarcinoma and giant cell tumor of the pancreas. Diag. Cytopathol. 4:316-322, 1988.
  21. Shambaugh III, G.E., Koehler, R.R., and J.A. Radosevich. Developmental Pattern of Poly (ADP-Ribose) Synthetase and NAD Glycohydrolase In the Brain of the Fetal and Neonatal Rat. Neurochemical Research, 13:973-981, 1988.   
  22. Kwaan, H.C., Radosevich, J.A., Xu, C.G., and D.W. Eggena. Presence of Inhibitors of Fibrinolysis in Malignant Melanoma.  Tumor Biology. 9:301-306, 1988.   
  23. Radosevich, J.A., Gould, V.E., Ma, Y., Lee, I., Thor, A., Carney, Warren, W.H.,  Schlom, J. and S.T. Rosen.  Immunohistochemical Analysis of Normal and Mutated ras Oncogene p21 Expression in Human Pulmonary and Pleural neoplasms. Virchows Arch of Pathology. B. 56:377-383, 1989.
  24. Radosevich, J.A., Combs, S.G., Ma, Y., Lee, I., Gould, V.E., Thor, A., Schlom, J. and S.T. Rosen.  Expression of ras Oncogene p21 during Human Fetal Development as determined by the Monoclonal Antibody RAP-5 and Y13-259. Virchows Arch of Pathology. B. 56:337-344, 1989.
  25. Robinson, P.G., Eggena, D.W., Koch, A.E., and J.A. Radosevich. A Double Staining Procedure Involving Immunohistochemical Staining with a Modified Prussian Blue Technique for Iron. Laboratory Medicine. 20:569-571, 1989.
  26. Keep, J.C., Benson III, A.B., Sullivan, M.D., Carney, W.P., Rosen, S.T., and J.A. Radosevich.  Immunohistochemical Analysis of Colon Adenocarcinoma with Monoclonal Antibody 47D10 and Anti-Carcinoembryonic Antigen. Tumor Biology. 10:153-163, 1989.
  27. Zimmer, A.M., Kazikiewicz, J.M., Webber, D.I., Patel, B.A., Goldman-Leikin, R., Radosevich, J.A., Spies, W.G., Spies, S.M., and S.T. Rosen. Stability of Radioiodinated Monoclonal Antibodies: In Vitro Storage and Plasma Analysis. International J. of Nuclear Medicine and Biology. 16:691-696, 1989.  
  28. Radosevich, J.A., Robinson, P.G., Rittmann-Grauer, L.S., Wilson, B., Leung, J.P., Maminta, M.L., Warren, W., Rosen, S.T., and V.E. Gould. Immunohistochemical Analysis of Pulmonary Carcinomas With The Monoclonal Antibody (MCA) HYB612 Directed Against The Multidrug Resistance MDR-1 Gene Product: P-glycoprotein.Tumor Biology. 10:252-257, 1989.
  29. Radosevich, J.A., Robinson, P.G., Carney, W.P., Warren, W., Rosen, S.T., and V.E. Gould. Immunohistochemical Analysis of Pulmonary and Pleural Neoplasms Using a Monoclonal Antibody (MCA) 47D10 Which Reacts With Nonspecific Cross Reacting Antigen (NCA). Tumor Biology. 10:281-288, 1990.
  30. Pensler, J.M., Langman, C.B., Radosevich, J.A., Maninta, M.L., Mangkornkanok, M., Higbee, R., and A. Molteni. Sex Steroid Receptors in Normal and Dysplastic Bone Disorders in Children. J. Bone and Mineral Research 5:493-498, 1990.
  31. Pensler, J.M., Radosevich, J.A., Higbee, R., and C.B. Langman. Osteoclast Isolated From Membranous Bone In Children Exhibit Nuclear Estrogen and Proesterone Receptors. J. Bone and Mineral Research 5:797-802, 1990.
  32. Jansson, D., Radosevich, J.A., Carney, W.P., Rosen, S.T., Schlom, J., Staren, E.D., Hyster, M.J., and V.E. Gould. Immunohistochemical Analysis of Ras Oncogene Expression in Epithelial Neoplasms of The Colon. Cancer 6:1329-1337, 1990.
  33. Shambaugh III, G.E., Clough, D., Munari, L., Koehler, R.R., and J.A. Radosevich. The Impact of Maternal Serum On Development of Enolase Activity In Fetal Rat Brain Cell Culture. Expt. Cell. Res. 186:210-217, 1990.
  34. Radosevich, J.A., Noguchi, M., Rosen, S.T., and Y. Shimosato. Immunocytochemical Analysis of Human Adenocarcinomas and Bronchioloalveolar Carcinomas of the Lung Using The Monoclonal Antibody 44 3A6. Tumor Biology. 11:181-188, 1990.
  35. Koukoulis, G.K., Radosevich, J.A., Rosen, S.T., and V.E. Gould. Immunohistochemica Study of Pulmonary and Pleural Tumors With  Monoclonal Antibodies (MAbs) B72.3 and CSLEX-1. Virchows Arch of Pathology. B. 58:427-433, 1990.                  
  36. Koch, A.E., Robinson, P.G., Radosevich, J.A., and R.M. Pope. Distribution of CD45RA and CD45RO T lymphocyte subsets in rheumatoid arthritis synovial tissue. J. Clin. Immun. 10:192-199,1990.
  37. Koch, A.E., Haines, G.K., Rizzo, R.R., Radosevich, J.A., Pope, R.M., Robinson, P.G., and W.H. Pearce. Human Abdominal Aortic Aneurysms: Immunophenotypic Analysis Suggesting an Immune Mediated Response.  Am. J. Path. 137:1199-1213, 1990.
  38. Radosevich, J.A., Siddiqui, F.S., Rosen, S.T., and W.J. Kabat. Cell Cycle and Electron Microscopic Evaluation of the Adenocarcinoma Antigen Recognized by the Monoclonal Antibody  44-3A6. British J. Cancer 63:86-87, 1991.
  39. Spagnolo, D.V., Witaker, D., Carrello, S., Radosevich, J.A., Rosen, S.T., and V.E.  Gould. The Use of Monoclonal Antibody 44-3A6 In Cell Blocks In the Diagnosis of  Lung Carcinoma, Carcinomas Metastatic To Lung and Pleura, and Pleural Malignant Mesothelioma. American J. Clinical Pathology 95:322-329, 1991.
  40. Radosevich, J.A., Maminata, M.L.D., Rosen, S.T., and V.E. Gould. A Simple and Inexpensive Approach To Determine the Amount of Paraffin Embedded Tissue Needed For DNA Molecular Analysis Using a Rapid Extraction Procedure. Laboratory Medicine 22:543-546, 1991.
  41. Kwaan, H.C., Keer, H.N., Radosevich, J.A., Cajot, J.-F. and R. Ernst. Components of  the Plasminogen-Plasmin System In Human Tumor Cell Lines. Sem. In Thrombosis and Hemostasis. 17:175-182, 1991.       
  42. Sinkule, J., Rosen, S.T., and J.A. Radosevich. MCA 44-3A6 Douxorubicin (Adriamycin) Immunoconjugates: Comparative In Vitro Anti-Tumor Efficacy of  Different Conjugation Methods. Tumor Biology 12:198-206, 1991.
  43.  Duda, R.B., August, C.Z., Rosen, S.T., and J.A. Radosevich. Monoclonal Antibody 44-3A6 as a Marker For Differentiation of Breast Cancer. Tumor Biology 12:254-260,1991.
  44. Radosevich, J.A., Combs, S.G., and S.T. Rosen. Expression of the epitope recognized by the monoclonal antibody 44-3A6 During human Fetal Development. Tumor Biology 12:321-329, 1991.
  45. Deftos, L.J., Martin, E.M., Gould, V.E., A. Hoog, S.T. Rosen, and J.A. Radosevich.Parathyroid Hormone-Related Protein, Chromogranin A, and Calcitonin Gene Products In Neuroendocrine Skin Carcinoma Cell Lines. J. Bone Mineral Res. 14:113-120, 1991.
  46. Yew, W.W., Kwan, S.Y.L., Lam, K.C., Chiu, K.Y., Hsu, C., Fu, K.H., and J.A. Radosevich. Application of Monoclonal Antibody 44-3A6 In the Cytological Diagnosis of Malignant Pleural Effusion and Histological Correlation In Lung Carcinoma. Lung Cancer 7:309-316, 1991.
  47. Barch, D.H., Jacoby, R.F., Brasitus, T.A., Radosevich, J.A., Carney, W.P., and P.M. Iannaccone. Incidence of Harvey-ras Oncogene Point Mutations and Their Expression in Methylbenzylnitrosamene Induced Esophageal Tumorigenesis. Carcinogenesis 12:2373-2377, 1991.
  48. Gu, D.S., Shambaugh, G.E., Metzer, B.E., Unterman, T.G., and J.A. Radosevich. Retardation of Fetal Brain Cell Growth During Maternal starvation: Cirulating Growth Factor Verus Altered Cellular Response. Neurochemical Research 17:529-537, 1992.
  49. Mittal, B.B., Zimmer, A.M., Sathiaseelan, V., Rosen S.T., Radosevich, J.A., Rademaker, A.W., Saini, A., Pierce, M.C., Webber, I.D., and S.M., Spies. Effects of Hyperthermia and 131-I  anti-CEA Monoclonal Antibody on  Human Xenografts in Nude Mice. Cancer 70:2785-2791, 1992.
  50. Ng, Y-K, Taborn, G., Ahmad, I., Radosevich, J.A., Bauer, K.D., and P. Iannaccone. Spatiotemporal Changes of ras p21 in Hepatocyte Cell Cycle During Liver Regeneration.Developmental Biology 150:352-362, 1992.
  51. Maker, V.K. and J.A. Radosevich. Reduced Tumor Cell Transfer With Contact Neodymium-Yttrium-Aluminium Garnett (Nd:YAG) Laser Scalpels.  Lasers In Surg. Med. 12:303-307, 1992.      
  52. Siddiqui, F.S., Iqbal, Z., and J.A. Radosevich. Changes in the expression of the tumor-associated antigen recognized by the MCA 44-3A6 in A549 cells due to  calcium. Tumor Biology, 13:142-151, 1992. 
  53. Haines, G.K., Ghadge, G., Thimmappaya, B., and J.A. Radosevich. Expression of the protein kinase p68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms. Virchows Arch. Path. B., 62:151-158, 1992.   
  54. Zimmer, A.M., Kuzel, T.M., Spies, W.G., Duda, R.B., Webber D.I., Kazikiewicz J.M.,Radosevich, J.A., LoCicero, J., Robinson, P.G., Gilyon, K.A., Samuelson, E., Spies, S.M., Rosen, S.T., and R.T. Maguire. Comparative pharmacokinetics of In-111 and Y-90 B72.3 in patients following single dose intravenous administration. Anti-body Immunoconjugates and Radiopharmaceuticals 5:285-294, 1992. 
  55. Mittal, B.B., Zimmer, A.M., Sathiaseelan, V., Saini, A., Rosen  S.T., Rademaker, A.W., Radosevich, J.A., M.C., Webber, I.D., and S.M., Spies. Hyperthermia-Induced Enhancement of 131-I anti-CEA Monoclonal Antibody on Human Colon Carcinoma Xenografts in Nude Mice. Endocurrietharapy/Hyperthermia Oncology: An International Journal 8:217-223, 1992.
  56. Haines, G.K., Ghadge, G., Combs, S.G., Leslie, W., Thimmappaya, B., and J.A. Radosevich. Immunohistochemical Detection of  Double-Stranded RNA-Dependent Protein Kinase (P-68) With A Novel Monoclonal Antibody TJ4C4: A Case Report of An AIDS-Associated Kaposi's Sarcoma Treated With Alpha-Interferon. Tumor Biology  13:324-329, 1993
  57. Cajulis, R.S., Szumel, R., Frias-Hidvegi, D., Combs, S.G., and J.A. Radosevich. Monoclonal antibody 44-3A6 as an adjunct in cytodiagnosis of adenocarcinomas in body fluids. Diagnostic Cytopath. 9:179-183, 1993.
  58. Radosevich, J.A., Gould, K.A., Koukoulis, G.K. Haines G.K., Rosen, S.T., Lee I, and V.E. Gould. Immunohistochemical analysis of ras oncogene p21 expression in human liver diseases. Ultrastructure. Path. 17:1-8, 1993.
  59. Radosevich, J.A., Maminta, M.L.D., and S.T. Rosen. A review of current methods to extract DNA from fixed - paraffin embedded tissues for molecular analysis. Labmedica10:13-17, 1993.
  60. Radosevich, J.A., Haines, G.K., Elseth, K.M., Shambaugh, G.E., and V. K. Maker.A new method for the detection of viable cells in  tissue sections using 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium Bromide (MTT): An  application in the assessment of tissue damage by surgical instruments. Virchow Archiv (B). 63:345-350, 1993.
  61. Haines, G.K., Ghadge, G., Becker, S., Kies, M., Pelzer, H., Thimmappaya, B., and J.A. Radosevich. Immunohistochemical Expression of The Double-Stranded RNA-Dependent Protein Kinase (P68) In Head and Neck Squamous Cell Carcinoma: Correlation with differentiation. Virchow Archiv (B) 63:289-295,1993.
  62. Shambaugh III, G.E., Radosevich, J.A., Glick R.P., Gu D.S., Metzgar, B.E., and T.G. Unterman. Insulin-like growth factors and binding proteins in the fetal rat: Alterations during maternal starvation and effects in fetal brain cell culture. Neurchem. Res.18:695-703, 1993.
  63. Haines, G.K., Ghadge G., and J.A. Radosevich. Expression of p68 protein kinase as recognized by the monoclonal antibody TJ4C4 during human fetal development. Tumor Biol. 14:95-104, 1993.
  64. Shambaugh, G., Glick, R., Radosevich, J., and T. Unterman. Insulin-like growth  factor-I and binding protein-1 (BP-1) can modulate fetal brain cell growth during maternal starvation. Ann. N. Y. Acad. Sci. 692:270-272, 1993.     
  65. Haines, G.K., Becker, S., Ghadge, G., Kies, M., Pelzer, H., and J.A. Radosevich. Expression of the double-stranded RNA-dependent protein kinase (P68) in squamous cell carcinoma of the head and neck region: Prognostic implications. Archives of Otolaryngology - Head & Neck Surgery 119:1142-1147, 199
  66. Pensler, J.M., Ledesma, D.F., Hijjawi J., and J.A. Radosevich. Plagiocephaly: Premature unilateral closure of the coronal suture: A potentially localized disorder of cellular metabolism. Annals Plastic Surg. 32:160-165, 1994.
  67. Shambaugh III, G.E., Unterman, T.G., Goolsby, C.L., Natarajan, N., Glick, R.P., Kelly, G.C., and J.A. Radosevich. Proliferative Growth of Neonatal Cerebellar Cells in Culture: Regulation by Maternal and Male Rat Serum. Neurochem. Res. 19:297-309, 1994. 
  68. Dubreuil, R., Souik, P., Haines G.K., and J.A. Radosevich. Monoclonal antibodies directed against human tumor associated antigens cross-react with Drosophila proteins in clusters. International J. of Cancer. 8:96-97, 1994.
  69. Natarajan, N., Shambaugh III, G.E., Elseth, K.M., Haines, G.K., and J.A.Radosevich. Adaptation of the Diphenylamine (DPA) Assay to a 96 Well Plate Tissue Culture Format and Comparison With the MTT Assay.  BioTechniques 17:166-171, 1994.
  70. Radosevich, J.A., Ghadge, G.D., Haines, G.K., P. Malhotra, and B. Thimmapaya. Characterization of the mouse monoclonal antibody TJ4C4 directed at human p68  kinase. Tumor Biology 15:225-262, 1994.
  71. Haines, G.K., and J.A. Radosevich. The double stranded RNA dependent protein kinase (p68) is a novel marker for differentiation in aerodigestive tumors. Proc. Inter. Cancer  Congress XVI (UICC) 3:1683-1686, 1995.
  72. Radosevich, J.A., Bradley, G.S., and K.M. Elseth. Molecular cloning of the human Nag gene and the expression of the adenocarcinoma associated antigen (labyrinthin): the antigen recognized by the monoclonal antibody 44-3A6. Proc. Inter. Cancer Congress XVI (UICC) 1:237-241, 1995
  73. Singh, C., Haines G.K., Talamonti, M.S., and J.A. Radosevich. Expression of p68 in human colon cancer correlates with cellular differentiation. Tumor Biology  16:281-289, 1995.
  74. Shambaugh, G.E., Maker, A., and J.A. Radosevich. A rapid method for simultaneous determination of protein and salt concentrations in ion exchange fractions. BioTechniques 19:725-28, 1995. 
  75. Maker, V.K., Elseth, K.M., and J.A. Radosevich. Reduced In Vivo local recurrenc with contact neodymium-yttrium-aluminium garnet (Nd:YAG) laser scalpels. Lasers In Surg. Med. 17:370-374, 1995.
  76. Haines, G.K., Cajulis, R.S., Hayden, R.T., Frias-Hidvegi, D., Duda, R.B., August C.Z., and J.A. Radosevich. P68 expression in breast neoplasms as detected by monoclonal antibody TJ4C4. Tumor Biology 17:5-12, 1996.     
  77. Potempa, L.A., Motie M., Wright K.E., Crump B.L., Radosevich, J.A., Sakai, N., Hua, L.G., Tanaka, K., Kojima, E., and A. Tsuboi. Stimulation of  megakaryocytopoiesis in mice by human modified-C-reactive protein (mCRP). Exper. Hema. 24:258-264, 1996.
  78. Bentz, B.G., Haines, G.K., Hanson, D.G., and J.A. Radosevich. Head and neck squamous cell carcinomas express a spectrum of constitutive. Biol. Nitric Oxide Part 5, Portland Press, London, 1996.
  79. Bentz, B.G., Barnes, M.N., Haines, G.K., Lurain J.R., Hanson, D.G., and J.A. Radosevich. Cytoplamic Localization of Endothelial Constitutive Nitric Oxide Synthase in Endometrial Carcinomas. Tumor Biology. 18:290-296, 1997.
  80. Bentz, B.G., Haines III, G.K., Hanson, D.G., and J.A. Radosevich. Endothelial constitutive nitric oxide synthase (ecNOS) localization in normal and neoplastic salivary  tissue. Head  & Neck. 20:304-309, 1998.
  81. Pensler, J.M., Ivescu, A.S., and J.A. Radosevich. Scaphocaly: Premature closure of the Sagittal Suture: A Localized disorder of cellular Metabolism. Annals Plastic Surg. 40:48-52, 1998.
  82. Haines III, G.K., Panos, R.J., Bak, P.M., Brown, T., Zielinski, M., Leyland, J., and J.A. Radosevich.  Interfeon-Responsive Protein Kinase (p68) and Proliferating Cell Nuclear Antigen Are Inversely Distributed in Head and Neck Squamous  Cell Carcinoma.  Tumor Biol. 19:52-59, 1998.
  83. Bentz, B.G., Haines, G.K., vonSchlegell, A.S., Elseth, K.M.,  Hanson, D.G., and J.A. Radosevich. Expression of the adenocarcinoma-related antigen  recognized by monoclonal antibody 44-3A6 in salivary gland neoplasia. Otolaryng.- Head & Neck Surg. 118:603-609, 1998
  84. Zhou, Y., Gobl, A., Wang, S., Jacobsen, M.B., Janson, E.T., Haines III, G.K., J.A. Radosevich, and K. Oberg. Expression of p68 protein kinase and its prognostic significance during INF-alpha therapy in patients with carcinoid tumors. Eur. J. Cancer 34: 2046-2052, 1998.
  85. Bentz, B.G., Haines III, G.K., and J.A. Radosevich. Nitrotyrosine Implicates Nitric Oxide  in Head and neck Squamous Cell Carcinoma. Proceedings of the 17th International Cancer Congress 17:547-550, 1998.
  86. Diehl, E.E., Radosevich, J.A., Haines III, G.K., Yokoo, H., and L.A. Potempa. Cellular Effects of the Modified Form of C-reactive Protein (mCRP) on Tumor Cells. Proceedings of the 17th International Cancer Congress, 17:167-170, 1998. 
  87. Kresl, J.J., Potempa, L.A., Anderson, B., and J.A. Radosevich. Inhibition of Mouse Mammary Adenocarcinoma (EMT6) Growth and Metastases in Mice by a Modified Form of C-Reative Protein. Tumor Biol. 20:72-87,1999.
  88. Bentz, B.G., Haines III, G.K., Hanson, D.G., and J.A. Radosevich. Nitric oxide synthase type 3 is Increased in Squamous Hyperplasia, Dysplasia, and squamous Cell Carcinoma of the Head and Neck. Ann Otol Rhinol Laryngol. 108:781-787, 1999.
  89. Bentz, B.G., Haines III, G.K., Lingen M.W., Pelzer, H.J., Hanson, D.G., and J.A. Radosevich. Nitric Oxide Synthase Type 3 is Increased In Squamous Hyperplasia and Dysplasia. Annals Otol.Rhino. & Laryng. 108:781-787, 1999.
  90. Bentz, B.G., Haines, G.K., and J.A. Radosevich. Glutathione s-Transferase pi in Squamous Cell Carcinoma of the Head & Neck. Laryngoscope. 110 (20 pt 1):1642-7, 2000
  91. Bentz, B.G., Haines III, G.K., Hanson, D.G., and J.A. Radosevich. Increased protein nitrosylation in head and neck squamous cell carcinogenesis. Head & Neck 22:64-70, 2000.
  92. Diehl, E.E., Haines III, G.K., Radosevich, J.A., and L.A. Potempa. Immunohistochemical Localization of Modified C-Reactive Protein antigen in normal vascular tissue. Am J Med Sci. 319(2) 79-83, 2000. 
  93. Bentz, B.G., Simmons, R.L., Haines III, G.K., and J.A. Radosevich. The Yin and Yang of Nitric Oxide. Reflections on the Physiology and Pathophysiology of NO. [Invited Review] Head & Neck. 22(1):71-83, 2000
  94. Chandra, R.K., Haines III, G.K., Bentz, B.G., Shah, P., Robinson, A.M., and J.A. Radosevich Expression of NOS3 in Reflux-Induced Lesions of the Esophagus. Otol Head Neck Surg. 124:442-7, 2001.
  95.  Chandra, R.K., Bentz, B.G., Haines, G.K., Robinson, A.M., and J.A. Radosevich. Expression of Glutathione s-Transferase pi in Benign Mucosa, Barrett’s Metaplasia, and Adenocarcinoma of the Esophagus. Head Neck 24:575-81, 2002.
  96. Bentz, B.G., Chandra, R.K., Haines III, G.K., Robinson, A.M., Shah, P., and J.A. Radosevich.  Nitric Oxide and Apoptosis in Human Head & Neck Squamous Cell Carcinoma Development. Am J Otol. Am. J Otolaryngol. 23:4-11, 2002.
  97. Altman, K.W., Haines III, G.K., Hammer, N.D., and J.A. Radosevich. The H+/K+ -ATPase (proton) Pump is Expressed in Human Laryngeal Submucoals Glands. Laryngoscope 113:1927-1930, 2003.
  98. Altman,  K.W., Haines III, G.K.,  Vakkalanka, S.K., Keni, S.P., Kopp, P.A., and J.A. Radosevich.        Identification of Thyroid Horome Receptors in the Human Larynx. . Laryngoscope 113:1931-1934, 2003.
  99. Bentz, B.G., Hammer, N.D., J.A. Radosevich, and G.K. Haines, III. Nitrosative Stress Induces DNA Strand Breaks but not Caspase Mediated Apoptosis in a Lung Cancer Cell Line. J Carcinogesis 3:1-19, 2004.
  100. Hammer, N.D., Lee, S., Vesper, B.J., Elseth, K.M., Hoffman, B.M., Barrett, A.G., and J.A. Radosevich. Charge Dependence of Cellular Uptake and Selective Antitumor Activity of  Porphyrazines. J. Med. Chem. 48:8125-8133, 2005.
  101. Altman KW, Waltonen JD, Hammer ND, Haines GK III, and JA Radosevich. “Proton pump expression in human laryngeal seromucinous glands,” Otolaryngology – Head & Neck Surgery,  133: 718-724, 2005.
  102.  Vesper, B. J.; Lee, S.; Hammer, N. D.; Elseth, K. M.; Barrett, A. G.; Hoffman, B. M.; Radosevich, J. A.  “Developing a Structure-Function Relationship for Anionic Porphyrazines Having Selective Anti-Tumor Activity.” J. Photochem. Photobio. B: Bio. 82:180-186, 2006.
  103.  Bentz, B.G., Hammer, N.D., Milash, B., Klein, S., Burnett, D.M., Radosevich, J.A., and G.K. Haines III. Nitric oxide’s kineteics and redox state determine the biological consequences in lung adenocarcinoma. Tumor Biology 28:301-11,2007.
  104. Vesper, B.J., Altman, K.W., Elseth, K.M., Haines III, G.K., Pavlova, S., Tao, L., Targan, G., and J.A. Radosevich. Gastroesophageal reflux disease (GERD): Is there more to the story? ChemMedChem, 3(4):552-559, 2008.
  105. Altman, K.W., Chhaya, V., Hammer, N.D., Pavlova, S., Vesper, B.J., Tao, L., and J.A. Radosvich. Effect of proton pump imhibitor Pantoprazole on growth and morphology of oral Lactobacillus strains. Laryngascope.118(4):599- 604, 2008.
  106.  Altman, KW, Waltonen, JA, Tarjan, G, Radosevich, JA, and GK Haines. “ Human Lung Mucus Glands Manifest Evidence of the H+/K+ -ATPase Proton Pump. Annual of Otology, Rhinology, and Laryngology 116:229-34, 2008.
  107. Lee, S., Vesper, B.J., Zong, H., Hammer, N.M., Elseth, K.M., Barrett, A.G.M., Hoffman, B.M., and James A. Radosevich. Synthesis and Biological Analysis of Thiotetra(ethylene glycol) monmethyl ether functionalized  Porphyrazines: Cellular Uptake and Toxicity Studies. Metal-Based Drugs 2008:391418, 2008.
  108. Wilkie, J.R., Roeske, J.C., Tiryaki, H., Smith, B.D, Radosevich, J.A. and B. Aydogan. Feasibility Study for Linac-Based Intensity Modulated Total Marrow Irradiation. Radiation Oncology, Biology & Physics  35(12):5609-18, 2008
  109. Albrecht, H., Radosevich, J.A., and M. Babich. Fundamentals of antibody-related therapy and diagnostics. Drugs of Today 45(3):199-211, 2009.
  110. Vesper, B.J., Jawdi, A., Altman, K.W., Haines III, G.K., Tao, L. and J.A. Radosevich. The Effect of Proton Pump Inhibitors on the Human Microbiota.  Current Drug Metabolism 10(1):84-89, 2009.
  111. Altman, M.B., Vesper, B.J., Smith, B.D., Stinauer, M.A., Pelizzari, C.A., Aydogan, B., Reft, C.S., Radosevich, J.A., Chmura, S.J., and J.C. Roeske. Characterization of a Novel Phantom for Three-Dimensional In Vitro Cell Experiments.  Physics in Medicine and Biology 54(5):N75-N82, 2009.
  112. Altman, K.W. and J.A. Radosevich. Unexpected Consequences of Proton Pump Inhibitor Use. Laryngascope. 141:564-566,  2009.
  113. Radosevich, J. A., Elseth, K. M., Vepser, B. J., Targan G., and G. K. Haines III. Long-Term Adaptation of Lung Tumor Cell Lines with Incrreasing Concentrations of Nitric Oxide Donor. The Open Lung Cancer Journal 2:35-44, 2009.
  114. Trivedi, E. R., Vesper, B.E., Weitman, H., Ehrenberg, B., Barrett, A.G.M., Radosevich, J.A., and B. M., Hoffman. Chiral Porphyrazines as Optical Agents for the Diagnosis and Treatment of Cancer. Photochemistry and Photobiology 86:410-417,  2010.
  115. Vesper, B.J., Elseth, K.M., Tarjan, G., Haines III, G.K., and  J.A. Radosevich. Long-Term Adaptation of  Breast Tumor Cell Lines to High Concentrations of Nitric Oxide. Tumor Biology 31:267-275,  2010.
  116. Paradise, W.A., Vesper, B.J., Goel, A., Waltonen, J.D., Altman, K.W., Haines, G.K., and J.A. Radosevich. Nitric Oxide: perspectives and Emerging Studies of a Well Known Cytotoxin. Inter. J. Mol. Sci.11:2715-45, 2010.
  117. Song, Y., Zong, H., Trivedi, E., Vesper, B., Waters, E., Barrett, A., Radosevich, J., Hoffman, B., and T. Meade. Synthesis and Characterization of New Porphyrazine- GD (III) Conjugates as Multimodal MR Contrast Agents. Bioconjugate Chem. 21:2267-75, 2010.
  118. Rubinstein, P.G., Lindgren, V., Setty, S., Yao, M., Pytynia, K., Radosevich, J.A., Kadkol, S.S., and L.E.Feldman. Durable Complete Remission Induced by Cetuximab Monotherapy in an HIV Infected Patient with Recurrent Squamous Cell Carcinoma of the Head & Neck. J. Clin. Onoc. 29:222-225, 2010.
  119. Yarmolyuk, Y., Vesper, B.J., Paradise, W.A., Elseth, K.M., Tarjan, G., Haines III, G.K., and J.A.Radosevich. Part I. Development of a Model System For Studying Nitric Oxide in Tumors: High Nitric Oxide-Adapted Head and Neck Squamous Cell Carcinoma Cell Lines. Tumor Biol. 32:77-85, 2010.
  120. Tarjan, G., Haines III, G. K., Vesper, B.J., Xue, J., Altman, M.B., Yarmolyuk, Y., Elseth, K.M., Roeske, J.,C., Aydogan, B., and J.A. Radosevich. Part II. Initial Molecular and Cellular Characterization of High Nitric Oxide-Adapted Human Tongue Squamous Cell Carcinoma Cell Lines. Tumor Biol. 32:87-98, 2010.
  121. Yeginer, M., Roeske, J.C., Radosevich, J.A., and B. Aydogan. Linear Accelerator-Based Intensity-Modulated Total Marrow Irradiation Technique for Treatment of Hematological Dosimetric Feasibility Study. Int. J. Radiat. Oncol. Biol. Phys. 79:1256-65, 2010.
  122. Aydogan, B, Yeginer, M., Kavak, G.O., Fan, J., Radosevich, J., and K. Gwe-Ya. Total Marrow Irradiation with RapidArc Volumetric Arc Therapy. Int. J. Radiat. Oncol. Biol. Phys. 81:592-599, 2011.
  123. Paradise, W.A.,  Vesper, B.J., Babich, M., Colvard, M.D., and J.A. Radosevich. Methods, Processes and Comparative Yield Economics for the Production of Antibodies, Recombinant Proteins. Immuno., Endo. & Metab. Agents in Med. Chem. 11:199-219, 2011.
  124. Altman, K.W., Kinoshito, Y., Tan-Geller, M., Burstein, D., and J. A. Radosevich. Western Blot Confirmation of the H+/K+-ATPase Proton Pump in the Human Larynx and Submandibular Gland. J. Human Larynx and Submandibular Gland. 145:783-788, 2011.
  125. Surucu, M., Yeginer, M., Kavak, G.O., Fan, J., Radosevich, J.A., B. Aydogan. Verification of Dose  Distribution For Volumetric Modulated Arc Therapy Total Marrow Irradiation In A Humanlike Phantom.Med. Phys. 39:281-288, 2012.
  126. Onul, A., Elseth, K., de Vitto, H., Paradise, W.A., Vesper, B.J., Tarjan, G., Haines III, G.K., Rumjanck, F. D., and J.A. Radosevich. Long-term Adaptation of The Human Lung Tumor Cell Line A549 to Increasing Concentrations of Hydrogen Peroxide. Tumor Biol. 33:739-748, 2012.
  127. Onul, A. Colvard, M., Paradise, W.A., Elseth, K.M., Vesper, B.J., Gouvas, E., Platt, F.J., Pestle, W., and   J.A. Radosevich. Development of a New Method Based On Antigen Destruction As A Measure of Tissue  Damage. J. Histochem. Cytochem. 60: 683-693, 2012.
  128. Vesper, B.J., Onul, A., Haines III, G.K., Targan, G., Xue, J., Elseth, K.M., Aydogan, B., Altman, M.B.,  Roeske, J.C., Paradise, W.A., De Vitto, H., and J. A. Radosevich. Part I. Molecular and Cellular Characterization of High Nitric Oxide – Adapted Human Breast Adenocarcinoma Cell Lines. Tumor Biol. 34:203-214,  2013 .
  129. De Vitto, H., Mendonca, B.S., Elseth, K.M., Vesper, B.J., Portari, E.A., Gallo, C.V.M., Paradise, W.A.,  Rumjanek, F.D., and J. A. Radosevich. Part II. Mitochondrial Mutational Status of High Nitric Oxide Adapted Cell Line BT-20 (BT-20-HNO) As It Relates To Human Primary Breast Tumors. Tumor Biol. 34:337-47,  2013.
  130. De Vitto, H., Mendonca, B.S., Elseth, K.M., Onul, A., Xue, J., Vepser, B.J., Gallo, C.V.M., Rumjanek,  F.D., Paradise, W.A., and J. A. Radosevich. Part III. Molecular Changes Induced By High Nitric Oxide Adaptation in Human Breast Cancer Cell Line BT-20 (BT-20-HNO): A Switch From Aerobic to Anaerobic Metabolism. Tumor Biol.  34:403-13, 2013.
  131. Breskey, J.D., Lacey, S.E., Vesper, B.J., Paradise, W.M., Radosevich, J.A., and M.D. Colvard.  Photodynamic Therapy: Occupational Hazards and Preventative Recommendations for Clinical Administration By Healthcare Providers. Photomedicine and Laser Surgery 31:398-407, 2013.
  132. Aqil, M., Elseth, K.M., Vesper, B.J., Aydogan, B., Xue, J., and J.A. Radosevich. Part I – Mechanism of Adaptation: High Nitric Oxide Adapted A549 Cells Show Enhanced DNA Damage Response And Activation Of Antiapoptic pathways. Tumor Biol. 35: 2403-2415, 2013.
  133. Aqil, M., Deliu, Z., Elseth, K.M., Shen, G., Xue, J., and J.A. Radosevich. Part II – Mechanism of aptation: A549 Cells Adapt To High Concentration of Nitric Oxide Through Bypass of Cell Cycle Checkpoints. Tumor Biol.  35:2417-2425, 2013.
  134. Aqil, M., Elseth, K.M., Arjunakani, A., Nebres, P., Amegashie, C.P., Desai, P.B., Thanki, D.H., and J.A. Radosevich. A549 Cells Adapted To High Nitric Oxide Show Reduced Surface CEACAM Expression and  Altered Adhesion and Migration Properties. Tumor Biol. 2014 (In Press).

Book Chapters:

  1. Radosevich, James A., Ma, Yixing, Weitzman, Sigmund A., Steven T. Rosen. Non-Small Cell Lung Cancer Antigens.  In:  Lung Biology in Health and Disease. L'Enfant, C., Abrams, P., Rosen, S.T. (Eds.),  p237-253, 1988.
  2. Radosevich, James A., Lee, Inchal, Gould, Victor E., and Steven T. Rosen. Monoclonal Antibody Assays For Lung Cancer.  In:  In Vitro Diagnosis of Human Tumors Using Monoclonal Antibodies.  H.Z. Kupchik, Noel Rose (Ed.) Immunology Series.  Marcel Dekker, p101-119, 1988.
  3. Rosen, Steven T., Radosevich, James A. and John Gruhn.  The Biology of Lung Cancer. In:  The History of Lung Cancer.  J.G. Gruhn (Ed.)  Grune and Stratton. p35-54, 1988.
  4. Rosen, Steven T. and James A. Radosevich.  Biology of Lung Cancer. In: Lung Cancer.Bitran, J.D. and Golumb, H.R. (Ed.)  Grune and  Stratton, p240-249, 1988.
  5. Kaplan, Edward H., Goldman-Leikin, Robin E., Radosevich, James A., Zimmer, A. Michael, and Steven T. Rosen.  Current Status of Monoclonal Antibodies in Cancer Therapy.  Proceedings of the Sixth Annual Symposium on Geriatrics and Gerontology - Cancer and Aging. T.V. Zenser and R.M. Coe (Eds), Springer Publishing Co., p86-109,1989.
  6. Radosevich, J.A., Ritts, R.E., and Rosen, S.T.  Immunology of Human Bronchial Cancer.In: General Thoracic Surgery. 3rd Ed., T.W.Shield (Ed), Lea & Febiger, p1211-1216,1989.
  7. Gruhn, J., Radosevich, J.A., and S.T. Rosen. Lung Cancer: Changing Concepts. In:Advances in Pathology, Vol. 3, Mosby Year Book Publishers, 1990.    
  8. Cohn, S.L., Robinson, P.G., Radosevich J.A. and S.T. Rosen. Tumor Markers and Phenotyping Techniques.  In Adjuncts In Surgery. S. Economous, Ed. 1991.
  9. Robinson, P.G. and J.A. Radosevich. Mediastinal Tumor Markers. In: The Mediastinum.T.W. Shields (Ed.). Lea and Febiger, 1991.
  10. Radosevich, J., Haines, G.K., Ghadge, G., and B. Thimmappaya. Double-Stranded RNA-Dependent Protein Kinase (P-68) As A Differentiation Marker In Human Lung Cancer. In: Lung Cancer Differentiation. Lung Biology in Health and disease. L'Enfant, C., Bernal, S., and Baylin, S. (Eds.). Marcel Dekker, 1992.
  11. Radosevich, J.A., Combs, S.G. and S.T. Rosen.  Immunohistochemical Analysis of Lung Cancer Differentiation Markers. In: Lung Cancer Differentiation. Lung Biology in Health and disease. L'Enfant, C., Bernal, S., and Baylin, S. (Eds.).Marcel Dekker, 1992.
  12. Shambaugh, III, G.E., Metzger, B.E., and J.A. Radosevich. Nutrient Metabolism and Fetal Brain Development. In: Perinatal Biochemistry. Emilio Herrera and Robert H. Knoop (Eds.), CRC Press, 1992.
  13. Radosevich, J.A., and Rosen, S.T.  Immunology of Human Bronchial Cancer.  In: General Thoracic Surgery. 4th Ed., T.W.Shield (Ed), Williams & Wilkins, 1994.
  14. Radosevich, J.A. Immunophenotyping of Lung Cancer. In: General Thoracic Surgery. 4th Ed., T.W.Shield (Ed), Williams & Wilkins, 1994.
  15. Shields, T.W., Robinson, P.G., and Radosevich, J.A. Lung Cancer - Etiology, Carcinogenesis and Pathology. In: General Thoracic Surgery. 4th Ed., T.W.Shield (Ed), Williams & Wilkins, 1994.
  16. Vesper, B.J., Barrentt, A.G.M., Hoffman, B.M., and J.A. Radosevich. Porphyrazine Anti-Tumor Agents, Clinical Chemistry  Research. Eds: B.H. Mitchem & C.L. Sharnham., Nova Science Publishers, Hauppauge NY, ISBN: 978-1-60692-517-1, 2009.
  17. Altman, K.W., Paradise, W.A, Vesper, B., and James A. Radosevich. Non-Gastric Proton Pumps As An Adjunctive Mechanism For Acid Secretions. In: Effects, Diagnosis and Management of Exrta-esophageal Reflux: A Multi-disciplinary Approach From World-Renowned Experts In The Field. N. Johnson (Ed)., 2010.
  18. Paradise, W. A.; Altman, K. W.; Vesper, B. J.; Radosevich, J. A. “Systemic Implications in the Pharmacologic Treatment of Gastroesophageal Reflux Disease (GERD).” In: Reflux Disease: Causes, Symptoms, and  Treatment.” Nova Science Publishers: New York, 2010.
  19. Xue, J., Vesper, B.J., and J.A. Radosevich. Human Papillomavirus: A Brief Overview. In: HPV and Cancer,J.A. Radosevich (Ed.), Springer Publishers, 2013.
  20. Xue, J., Vesper, B.J., and J.A. Radosevich. Proteins Encoded By The Human Papillomavirus Genome and  Their Functions. In: HPV and Cancer, J.A. Radosevich (Ed.), Springer Publishers, 2013.
  21. Xue, J., Vesper, B.J., and J.A. Radosevich. The Life Cycle of Human Papillomavirus. In: HPV and Cancer, J.A. Radosevich (Ed.), Springer Publishers. 2013.
  22. J.A. Radosevich. Overview of “Head & Neck Cancer: Current Perspectives, Advances, and Challenges.” In: Head & Neck Cancer: Current Perspectives, Advances, and Challenges. J.A. Radosevich (Ed.), Springer Publishers 2013.
  23. Paradise, W.A., and J.A. Radosevich. Viruses and Head & Neck Cancer. In: Head & Neck Cancer: Current Perspectives, Advances, and Challenges. J.A. Radosevich (Ed.), Springer Publishers  2013.
  24. Bassiony, M., Aydrogan, B., and J.A. Radosevich. Diagnostic Imaging Considerations. In: Head & Neck Cancer: Current Perspectives, Advances, and Challenges. J.A. Radosevich (Ed.), Springer Publishers 2013.
  25. Paradise, W.A., and J.A. Radosevich. Biological treatments (Antibodies). In: Head & Neck Cancer: Current Perspectives, Advances, and Challenges. J.A. Radosevich (Ed.), Springer Publishers 2013.
  26. Aqil, M. and J.A. Radosevich. Mechanisms of Nitric Oxide Mediated UV Resistance in Solid Tumors. In: UV Radiation: Properties, Effects, and Applications , Nova Scientific Publishers 2014.
  27. Demircan, B., Deliu, Z., Alkoc, O.A. and J.A. Radosevich. The Use of UV Lasers in Fluorescent Activated Cell Sorter Analysis. In: UV Radiation: Properties, Effects, and Applications, Nova Scientific Publishers 2014.

Books:

  1. J.A. Radosevich. (Ed.) HPV and Cancer. Springer Publishers, 2013.
  2. J.A. Radosevich (Ed.) Head & Neck Cancer: Current Perspectives, Advances, and Challenges. Springer Publishers . 2013.
  3.  J.A. Radosevich (Ed.) UV Radiation: Properties, Effects, and Applications. Nova Scientific Publishers. 2014.
  4. J.A. Radosevich (Ed.) Apoptosis and Beyond: The Many Ways Cells Die. (Part I), Springer Publishers. (In Press); 2015.
  5.  J.A. Radosevich (Ed.) Apoptosis and Beyond: The Many Ways Cells Die. (Part II), Springer Publishers. (In Press); 2015.

Abstracts:

  1. Radosevich, James A. and A. Galsky.  Ion Uptake and Crown-gall Tumor Formation. Plant physiol. Suppl. 61: 72 (Presented at the American Society of Plant Physiology Meetings.  Blacksburg, Virginia, 1978.)
  2. Radosevich, James A. and S.L. Barclay.  Membrane Topology of Developmentally Regulated Antigenic Determinants of Dictyostelium discoideum. (Presented at the Sigma Xi Graduate Student Research Forum, Chicago, Illinois, 1982.)
  3. Radosevich, James A. and S.L. Barclay.  Partial Characterization of the Glycolipid-Like Plasma Membrane Components of Dictyostelium discoideum and Polysphondylium violaceum. (Presented at the International Cellular Slime Mold Conference, Hartford,Connecticut,1982).
  4. Radosevich, James A. and S.L. Barclay. Characterization and Topology of Glycolipid-Like Components of Dictyostelium discoideum and Polysphondylium violaceum. (Presented at the Annual Meeting of the American Society of Microbiology, New Orleans, Louisiana,1983.)
  5. Radosevich, James A. and S.L. Barclay.  Development of a New Hydrophobic Stain for Polyacrylomide Gels: The Hydrophobic Association Stain.(Presented at the Annual Meeting of the American Association for the Advancement of Science, Detroit, Michigan,1983.)
  6. Radosevich, James A. and S.L. Barclay.  Developmentally Regulated Plasma Membrane Components of Dictoyostelium discoideum: Identification of Peripheral and Integral Proteins.(Presented at the Midwest Regional Developmental Biology Conference, W.Lafayette, Indiana, 1983.)
  7. Radosevich, James A. and S.L. Barclay.  Developmentally Regulated Cytoskeletal Components of Dictyostelium discoideum.  (Presented at the Midwest Regional Developmental Biology Conference, W. Lafayette, Indiana, 1983.)
  8. Radosevich, James A., 1983.  Characterization of Dictyostelium discoideum Plasma Membrane Components.  (Dissertation Abstracts International, Volume 45, Number 02, 1984.)
  9. Radosevich, James A., Radosevich, E.A. and S.L. Barclay.  A Mathematical Model Which Predicts the Molecular Composition and Structure of the Glycolipid-Like Components of Dictyostelium discoidium and Polysphondylium violaceum.(Presented at the Annual Meeting of the American Society of Microbiology, St. Louis, Missouri, 1984.)
  10. Radosevich, James A., Jung, L.K.F., Ma, Y., and S.T. Rosen. A Monoclonal Antibody Directed Against A Cell Surface Antigen On Human Adenocarcinoma of the Lung.(Presented at the Midwest Section of the American Federation For Clinical Research,Chicago,  Illinois, 1984.)
  11. Radosevich, J.A., Lambiase, E.A., Ma, Y., Salwen, H. and S.T. Rosen. Monoclonal Antibody 461D8 Reacts with A Cell Surface Component On Human Adenocarcinoma of the Lung.  (Presented at The Fourth Annual Congress For Hybridoma Research,San Francisco, California, 1985.)
  12. Zimmer, A.M., Rosen, S.T., Spies, S.M., Radosevich, J.A. and D.I. Webber.Radioimmunoscintigraphy of Human Lung Adenocarcinoma with 131I Tumor-Specific Monoclonal Antibody.  (Fourth Annual Congress for Hybridoma Research, San Francisco, California, 1985.)
  13.  Rosen, S.T., Runge-Morris, M., Lee, I.C., Ma, Y., Salwen, H., Zimmer, A.M., Gould,V.E. and J.A. Radosevich.  A Monoclonal Antibody Which Reacts with A Cell Surface Antigen on Human Adenocarcinoma of The Lung.  (Annual Meeting of The American Association for Clinical Research, Houston, Texas, 1985.)
  14. Radosevich, J.A., Koehler, R.R. and G.E. Shambaugh.  Circulating Factors During Maternal Starvation May Alter Development of Acetylcholinesterase In Fetal Rat Brain. (Presented at the National American Federation for Clinical Research, Washington, D.C.,1985.)
  15. Lee, I., Gould, V.E., Radosevich, J.A., Ma, Y. and S.T. Rosen. Immunohistochemical Staining of Various Lung Carcinoma Types with Monoclonal Antibody 44-3A6 (National American Federation for Clinical Research. Washington, D.C., 1985.)
  16. Radosevich, J.A., Ma, Y., Salwen, H.R., Jung, L.K.F., Combs, S.G., Lee, I., Gould, V.E., and S.T. Rosen.  Characterization of Lung Cancer Cell Surface Antigens Using Monoclonal Antibodies as Specific Probes. (Presented at the IV World Conference on Lung Cancer, Toronto, Canada, 1985.)
  17. Lee, I., Radosevich, J.A., Rosen, S.T., Ma, Y. and V.E. Gould. Immunohistochemical Staining of Various Lung Carcinomas with Monoclonal Antibody 44-3A6.  (IV World Conference on Lung Cancer, Toronto, Canada, 1985.)
  18. Zimmer, A.M., Rosen, S.T., Spies, S.M., Radosevich, J.A., Webber, D.I. and J.M. Kazikiewicz.  Radioimmunoscintigraphy of Human Lung Adenocarcinoma with I-131 Tumor-Specific Monoclonal Antibody. (Annual Meeting of the Society of Nuclear Medicine, Chicago, Illinois, 1985.)
  19. Shambaugh, G.E., Koehler, R.R. and J.A. Radosevich.  Nutritional Impact on Fetal Brain Development: A New In Vitro Model Which Parallels in Vivo Responses.(Midwest Section of the American Federation for Clinical Research, Chicago, Illinois, 1985.)
  20. Combs, S.G., Rosen, S.T., Ma, Y., Lee, I., Gould, V.E. and J.A. Radosevich.Immunohistochemical Detection of an Antigenic Determinant Expressed on Select Human Adenocarcinomas.  (Midwest Section of the American Federation for Clinical Research, Chicago, Illinois, 1985.)
  21. Rosen, S.T., Gould, V.E., Salwen, H., Lee, I., Bauer, K., Marder, R., Anderson, R., Kies, M., Moll, M., Franke, W., and J.A. Radosevich. Characterization of a Neuroendocrine Skin Carcinoma Cell Line: In Vitro Similarities with Bronchopulmonary Neuroendocrine Carcinomas. (Midwest Section of the American Federation for Clinical Research, Chicago, Illinois, 1985.)
  22. Banner, B.F., Gould, V.E., Lee, I., Ma, Y., Radosevich, J.A. and S.T. Rosen. Detection of Phenotypic Exocrine Features in Large Cell Undifferentiated Carcinomas of the Lung with MCA 44-3A6. (International Academy of Pathology, New Orleans, Louisiana,1986.)
  23. Lee, I., Radosevich, J.A., Ma, Y., Chejfec, G., Rosen, S.T. and V.E. Gould.Immunohisto-chemical Analysis of Pleural Mesotheliomas With Monoclonal Antibodies 44-3A6 and 624A12. (International Academy of Pathology, New Orleans, Louisiana, 1986.)
  24. Gould, V.E., Rosen, S.T., Salwen, H.R., LeBeau, M.M., Lee, I., Bauer, K.D., Marder,R., Moll, R., Franke, W.W. and J.A. Radosevich. Establishment and Characterization of a Neuroendocrine Skin Carcinoma Cell Line. (International Academy of Pathology, New Orleans, Louisiana, 1986.)
  25. Combs, S.G., Lee, I., Gould, V.E., Ma, Y., Rosen, S.T. and J.A. Radosevich.Immunohistochemical Detection of The Antigenic Determinant Recognized By The Monoclonal Antibody 44-3A6 on Select Human Adenocarcinomas.  (International Academy of Pathology, New Orleans, Louisiana, 1986.)
  26. Shambaugh, G.E., Koehler, R.R. and J.A. Radosevich.  Nutritional Impact on Fetal Brain Development:  A New In Vitro Model Which Parallels In Vivo Responses. (FASEB, St. Louis, Missouri, 1986.)
  27.  Shambaugh, G.E., Koehler, R.R., and J.A. Radosevich.  Circulating Factors May Modulate Acetylcholinesterase Levels In Fetal Rat Brain During Maternal Starvation.(The Endocrine Society Annual Meeting.  Anaheim, California, 1986.)
  28. Zimmer, A.M., Radosevich, J.A., Kazikiewicz, J.M., Spies, S.M., Rosen, S.T., Johnson,D.K. and R.L. Vessella,  Pharmacokinetics and Radioimmunoimaging of Radiolabeled Monoclonal Antibodies to Human Lung Adenocarcinoma.  (Society of Nuclear Medicine 33rd Annual Meeting, Washington, D.C., June 1986.)
  29. Radosevich, J.A., Mulshine, J.L., Zimmer, A.M. and S.T. Rosen. Monoclonal Antibodies In Immunodiagnosis and Immunotherapy of Human Lung Cancer. (Presented at the 14th International Cancer Congress, Budapest, Hungary, 1986.)
  30. Radosevich, J.A., Lee, I., Ma, Y., Gould, V.E., Carney, W.P. and S.T. Rosen.Comparison of the Expression of Normal and Mutated ras p21 Oncogene Products in Human Lung Neoplasms Detected by the Monoclonal Antibodies RAP-5 and DWP. (Presented at the Midwest Section of the American Federation of Clinical Research, Chicago, Illinois, 1986.)
  31. Ma, Y., Lee, I., Radosevich, J.A., Gould, V.E., Thor, A., Schlom, J., and S.T. Rosen. Immunohistochemical Analysis of Pulmonary Carcinomas with Monoclonal Antibody B72.3. (The Midwest Section of the American Federation of Clinical Research,Chicago, Illinois, 1986.)
  32. Combs, S.G., Radosevich, J.A., Ma, Y., Lee, I., Gould, V.E., Thor, A., Schlom, J., and S.T. Rosen.  RAP-5 Immunohistochemical Detection of the Expression of ras Oncogene p 21 In Human Fetal Tissues. (The Midwest Section of the American Federation of Clinical Research, Chicago, Illinois, 1986.)
  33. Lee, I., Radosevich, J.A., Ma, Y., Gould, V.E., Thor, A., Schlom, J. and S.T. Rosen. Expression of ras Oncogene p21 in Human Lung Carcinomas Detected by Monoclonal Antibody RAP-5.  (The Midwest Section of the American Federation of Clinical Research, Chicago, Illinois, 1986.)
  34. Shambaugh, G.E., Koehler, R. and J.A. Radosevich.  Circulating Factors May Contribute to Adaptive Responses in Fetal Rat Brain During Maternal Starvation. (The Midwest Section of the American Federation of Clinical Research, Chicago, Illinois, 1986).
  35. Lee, I., Radosevich, J., Carney, W., Ho, M., Rabin, H., Ma, Y., Warren, W., Rosen, S. and V. Gould.  Immunohistochemical Analysis of Pulmonary and Pleural Neoplasms Using Monoclonal Antibody 47D10.  (The International Academy of Pathology, Chicago, Illinois, 1987.)
  36. Lee, I., Radosevich, J., Carney, W., Rabin, H., Ma, Y., Scholm, I., Rosen, S. and V.Gould.  Immunohistochemical Detection of Unaltered and Mutated ras Oncogene Products in Pulmonary Neoplasma.  (The International Academy of Pathology, Chicago, Illinois, 1987.)
  37. Curruthers, Mary M., Kabat, William J., Ma, Yixing, Rosen, Steven T. and James A.Radosevich.  Monoclonal Antibodies Directed Against Cell Surface Antigens of Vibrio vulnificus.  (American Society of Microbiology, Atlanta, Ga., 1987.)
  38. Piehl, M.R., Lee, I., Ma, Y., Warren, W.H., Radosevich, J.A., Rosen, S.T. and V.E.Gould.  Subsets of Pulmonary Large Cell Undifferentiated Carcinomas Defined Immunohistochemically.  (The International Academy of Pathology, Chicago,Illinois, 1987.)
  39. Combs, S., Hidvegi, D., Ma, Y., Rosen, S.T., and J.A. Radosevich. Evaluation of a Pleomorphic Adenocascinoma of the Pancreas With The Monoclonal Antibody 44-3A6.
  40. (The 35th Annual Meeting of the American Society of Cytology, San Francisco,California, 1987.)
  41. Barch, D., Radosevich, J., Carney, W., and P. Iannaccone. Evidence Supporting a G->A Transition at Position 34 in H-ras-1 in Methylbenzylnitrosamine Esophageal Tumorigenesis.  (The American Society of Cell Biology, St. Louis, Missouri, 1987.)
  42. Keep, J.C., Benson, III, A.B., Ma, Y., Carney, W.P., Rosen, S.T.and J.A. Radosevich. Immunohisto chemical Analysis of Colon Adenocarcinoma with Monoclonal Antibody 47010. (The American Federation of Clinical Research, Chicago, Illinois, 1987.)
  43. Robinson, P.G., Radosevich, J.A., Stahel, R.A., Waibel, R., Ma, Y., Gould, V.E., and S.T. Rosen.  Immunohistochemical Analysis of  Human Pulmonary Carcinoma Using SWA20.  (The American Federation of Clinical Research, Chicago, Illinois, 1987.)
  44. Shambough III, G.E., Koehler, R.R., and J.A. Radosevich. Mechanisms Underlying the Adaptive Responses of Fetal Brain to Maternal Starvation. (The American Federation of Clinical Research, Chicago, Illinois, 1987.)
  45. Shambaugh III, G.E., Koehler, R.R., and J.A. Radosevich. Altered Development of Fetal Brain Cells by Adult Serum: The Impact of Starvation.(FASEB, San Diego, California,1988.)
  46. Kaplan, E.H., Zimmer, A.M., Lurain, J., Miller, D.S., Kazikiewicz, J.M., Goldman-Leikin, R.E., Manzel, L., Spies, S.M., Spies, W.G., Radosevich, J.A., Hidvegi, D., and S.T. Rosen.  Intraperitoneal (IP) Infusion of 131I-Labeled Murine Monoclonal Antibody (B72.3) for Radioimaging (Dx) and Radioimmunotherapy (Tx) of Advanced Ovarian Cancer. (American Association of Clinical Research, New Orleans, Louisiana, 1988.)
  47. Zimmer, A.M., Kaplan, E.H., Lurain, J., Miller, D.S., Kazikiewicz, J.M., Goldman-Leikin, R.E., Radosevich, J.A., Manzel, L., Spies, W.G., Hidvegi, D., Silverstein, E.A., Spies,S.M., and S.T. Rosen. Pharmacokinetics of 131I-Labeled B72.3 in Patients with Advanced Ovarian Cancer Following Intraperitoneal Infusion. (The Society of Nuclear Medicine 35th Annual Meeting, San Francisco, California, 1988.)
  48. Robinson, P.G., Radosevich, J.A., Stahel, R.A., Waibel, R., Ma, Y., Gould, V.E.,and S.T. Rosen.  Detection of the Antigen Recognized by the Monoclonal Antibody (MCA) SWA20 In Human Pulmonary Neoplasms.  (Fifth World Conference on Lung Cancer, Interlaken, Switzerland, 1988.)
  49. Radosevich, J.A., Robinson, P.G., Rittmann-Grauer, L.S., Wilson, B., Leung, J.P., Ma, Y., Maminta, L., Warren W., Gould, V.E., and S.T. Rosen. Immunohistochemical Analysis of Pulmonary Carcinomas with the Monoclonal Antibody (MCA) HYB612 Directed Against a Multiple Drug Resistance Related Antigen. (Presented at the Fifth World Conference on Lung Cancer, Interlaken, Switzerland, 1988.)
  50. Radosevich, J.A., Ma, Y., Waibel, R., Maminta, L., Stahel, R.A., and S.T. Rosen. Partial Purification and Characterization of the Antigen recognized by the monoclonal antibody (MCA) 44-3A6 from the Human Lung Adenocarcinoma (AC) Cell Line A549. (Presented at the Fifth World Conference on Lung Cancer, Interlaken, Switzerland, 1988.)
  51. Gould, V.E., Piehl, M.R., Radosevich, J.A., Warren, W.H., Ma, Y., and S.T. Rosen. Exocrine and Neuroendocrine Subsets of Large Cell Lung Carcinomas Identified by Immunohistochemistry.  (Fifth World Conference on Lung Cancer, Interlaken, Switzerland, 1988.)
  52. Keep, J.C., Benson, A.B., Ma, Y., Rosen, S.T., Radosevich, J.A. and Carney W.P. Immunohistochemical Phenotyping of Colorectal Adenocarcinmas With Five Monoclonal Antibodies (The American Society of Clinical Pathologist Annual Meeting, Las Vegas, Nevada, 1988.)
  53. LoCicero III, J., Spies, W.G., Rosen, S.T., Zimmer, A.M.,  Robinson, P.G., Radosevich, J.A., Kaplan, E.H., Canade, A.B., Manzel, L., Spies, S.M., and Maguire, R.T. Preoperative Radionuclide Monoclonal Antibody (MCA) Imaging of Lung Cancer. (Fifth World Conference on Lung Cancer, Interlaken, Switzerland, 1988.)
  54. Spies, W.G., Zimmer, A.M., Robinson, P.G., LoCicero, J., Radosevich, J.A., Kaplan, E.H., Canade, A.B., Manzel, L., Spies, S.M., Maguire, R.T., and S.T., Rosen.Monoclonal Antibody Imaging Using In-III-Labeled B72.3 In Human Non-Small Cell Lung Carcinoma (NSCLC). (The Society of Nuclear Medicine 35th Annual Meeting, San Francisco, California, 1988).
  55. Robinson, P.G., Eggena, D.W., Koch, A.E., and J.A. Radosevich. Immunohistochemical Analysis of Iron Containing Tissues In Combination with a Modified Prussian Blue Stain: Clarification of Possible False Positive Staining. (The American Federation of Clinical Research, Chicago, Illinois, 1988.)
  56. LoCicero,III, J., Peplinski, G.R., Radosevich, J.A., Rosen, S.T., and L.L. Michaelis. Dose Response Variation to Photodynamic Therapy of In Vitro Human Lung Cancer Cell Lines. (American Association of Clinical Research, San Francisco, California, 1989.)
  57. Koukoulis, G.K., Radosevich, J.A., Rosen, S.T., and V.E. Gould. Immunocytochemical Study of Pulmonary and Pleural Tumors With Monoclonal Antibodies (MAbs) B72.3 and CSLEX-1. (The International Academy of Pathology, San Francisco, California, 1989.)
  58. Shambaugh, G.E., Koehler, R.R., and J.A. Radosevich. Maternal Serum Inhibits Fetal Brain Cell Growth In Vitro: Implications For Development. (FASEB, New Orleans, Louisiana, 1989.)
  59. Peplinski, G.R., LoCicero, J., Radosevich, J.A., Rosen, S.T., and L.L. Michaelis. Response of Human Lung Cancer Cell Lines In Vitro To Photodynamic Therapy.(Midwest Student Medical Research Forum, Omaha, Nebraska, 1989.)
  60. Benson, III, A.B., Rosen, S.T, Salwen, H., Goldman-Leikin, R., Radosevich, J., Gilyon, K., Duda, R., Kies, M., and M. Hanna. A Pilot Study of Active-Specific Immunotherapy With Autologous Tumor Cell (ATC)-BCG Vaccine and 5-Fluorouracil (5-FU) In Metastic Colorectal Carcinoma (CRC). (American Association of Clinical Research, San Francisco, California, 1989.)
  61. Koch, A.E., Robinson, P.G., Radosevich, J.A., and R.M. Pope. Immunophenotyping of Rheumatoid (RA) Synovial Tissue Lymphocytes. (American Rheumatism Association 53rd Annual Scientific Meeting. Cincinnati, Ohio, 1989.)
  62. Zimmer A.M., Kazikiewicz, J.M., Kaplan, E.H., Lurain, J., Miller, D.S., Webber, D.I., Patel, B.A., Goldman-Leiken, R.E., Manzel, L., Gilyon, K., Radosevich, J.A., Spies, W.G., Spies, S.M., and S.T.  Rosen. Human Antimurine Antibody Responses Following Intraperitoneal Radioimmunotherapy Infusions of Murine Monoclonal Antibodies: Pharmacokinetic Analysis Following Retreatment. (The Society of Nuclear Medicine 36th Annual Meeting, St. Louis, Missouri, 1989.)
  63. Zimmer A.M., Kazikiewicz, J.M., Webber, D.I., Patel, B.A., Goldman-Leiken, R.E., Radosevich, J.A., Spies, W.G., Spies, S.M., and S.T. Rosen. Stability of Radioiodinated Monoclonal Antibody Therapy Solutions: In Vitro Storage and Plasma Analysis. (The Society of Nuclear Medicine 36th Annual Meeting, St. Louis, Missouri, 1989.)
  64. Pensler, J., Langman, C., Radosevich, J., Mangkornanok-Mark, M., Higbee, R., Bauer,B., Patel, D., and M. Christensen. Estrogen Receptor Density and In Vitro Cellular Metabolism in Normal and Abnormal Osteoblasts.(Plastic Surgery Research Council, 1989.)
  65. Kwaan, H.C., Radosevich, J.A., Lastre, C., and W. Kabat. Components of the Fibrinolytic System in Human Tumor Cell Lines. (The XIIth ISTH, 1989.)
  66. Maker, V.K., and J.A. Radosevich. Clinical Implications of Contact Neodymium:YAG Laser In General Surgery: A Report on 100 Cases.(American College of Surgeons XXXXth Annual Clinical Congress, Atlanta, Ga., 1989.)
  67. Yew, W.W., Kwan, S.Y.L., Lam, K.C., Chui, K.Y., Hsu, C. and J.A. Radosevich.Application of Monoclonal Antibody MCA 44-3A6 In The Cytological Subtyping of Malignant Pleural Effusion and Differential Diagnosis of Exudative Pleural Effusion. (Australian Thoracic Society Meeting, New Zealand, 1989.)
  68. Maker, V.K., and J.A. Radosevich. In Vitro Evidence That The Contact Neodymium-Yttrium-Aluminium Garnett (Nd:YAG) Laser Inhibits "Knife" Metastasis. (The American Federation of Clinical Research, Chicago, Illinois, 1989.)
  69. Radosevich, J.A., Jansson, D.S., Siddiqui, F.S., Piehl, M., Kabat, W., Gruhn, Rosen, S.T.,  and V.E. Gould. Subcellular Localization, Cell Cycle Analysis, and Frequency of Expression by Metastic Lesions of the Human Adenocarcinoma Antigen Recognized by The Monoclonal Antibody 44-3A6. (The American Federation of Clinical Research,Chicago, Illinois, 1989.)
  70. Haines, G.K., Ghadge, G., Combs, S.G., Leslie, W., Thimmappaya, B., and J.A. Radosevich. Immunohisto chemical Detection of Double-Stranded RNA-Dependent Protein Kinase (P-68) With a Novel Monoclonal Antibody TJ4C4: A Case Report of an AIDS-Associated Koposi's Sarcoma Patient Treated With Alpha-Interferon.(The American Federation of Clinical Research, Chicago, Illinois, 1989.)
  71. Shambaugh, G.E., Koehler, R.R., Clough, D., and J.A. Radosevich. A Gestationally Derived Growth Inhibitor. (The American Federation of Clinical Research, Chicago, Illinois, 1989.)
  72. Rizzo, R., Haines, G.K., Pierce, W.H., Pope, R., Radosevich, J.A., and P. Robinson. Characterization of The Inflammatory Cells In Abdominal Aortic Aneurysms. (23rd Annual Meeting of The Association for Academic Surgery, Louisville, Kentucky, 1989.)
  73. Ng, Y.K., Radosevich, J.A., Garton, R., Motimoto, R., and P.M. Iannaccone.Expression of Heat-Shock (hsp70) and ras Genes In Compensatory (Regenerative) Liver Growth: in situ Mosaic Pattern Analysis In Chimeric Rats. (The Annual Meeting of The ASCB,1989.)
  74. Holets-McCormack, S., Radosevich, J.A., and I. Tribby. Purification Of Human IgM Monoclonal Antibody. (The First International Hybridoma Conference, Orlando, Florida, 1990.) 
  75. Kwaan, H.C., Radosevich, J.A., and W. Kabat. Components of the Fibrinolytic system in human tumor cell lines. (American Association of Cancer Research, Washington, DC. 1990.)
  76. Maker, V.K. and J.A. Radosevich. Neodymium-Yttrium-Aluminium Garnett (ND:YAG)
  77. Contact Laser Scalpels Inhibit “Knife” Metastasis In Vitro. (Laser 90 International Conference, Machester, United Kingdom, 1990.)
  78. Shambaugh, G.E., Koehler, R.R., Clough, D., and J.A. Radosevich. A Circulating Factor In Late Gestation Inhibits Prolifative Growth In Cerebellar Cells. (The Endocrine Society, Atlanta, Georgia, 1990.)
  79. Kwaan, H.C., Radosevich, J.A., Cajot, J.-F., Ernst, R., and W. Kabat. Components of the Plasminogen-Plasmin System In Human Tumor Cell Lines.(Tenth International Congress on Fibrinolysis, Indianapolis, Indiana, 1990.)
  80. Koch, A.E., Haines, G.K., Rizzo, R.R., Radosevich, J.A., Pope, R.M., Robinson, P.G.,and W.H. Pearce. Human Abdominal Aortic Aneurysms: Immunophenotypic Analysis Suggesting an Abarrant Immune Response. (American Federation of Clinical Research,1990).
  81. Yew, W.W., Kwan, S.Y.L., Wong, P.C., Lam, K.C., Chiu, K.Y., Fu, K.H., and J.A. Radosevich. Application of MCA 44-3A6 in Classification of Thoracic Tumors Diagnosed by Percutaneous Transthoracic Needle Biopsies. (International Congress: Joint II Asian-Pacific Society of Respirology and Indonesian Society of Pulmonologist, Bali, 1990).
  82. Radosevich, J.A., Siddiqui, F.S., Rosen, S.T., and W.J. Kabat. Electron Microscopic Evaluation and Cell Cycle Analysis of the Human Adenocarcinoma Antigen Recognized By the Monoclonal Antibody 44-3A6. (Presented at the Second International Workshop On Small Cell Lung Cancer, London, United Kingdom, 1990). 
  83. Radosevich, J.A., Combs, S.G., and S.T. Rosen. Human Fetal Expression of the Adenocarcinoma Associated Antigen Recognized by the Monoclonal Antibody 44-3A6. (American Federation of Clinical Research, Chicago, IL, 1990.)
  84. Haines G.K., Ghadge, G., Becker, S., Kies, M., Pelzer, H., Thimmappaya, B., and J.A.Radosevich. Correlation between the expression of Double-Stranded RNA-Dependent protein Kinase (P-68) with Squamous Cell Carcinoma Differentiation. (American Federation of Clinical Research, Chicago, IL, 1990.)   
  85. Maker, V.K., Elseth, K.M., and J.A. Radosevich. The Contact Neodymium-Yttrium-Aluminum (Nd:YAG) Laser Reduces Local Recurrence of Tumor Growth. (American Federation of Clinical Research, Chicago, IL, 1990.)   
  86. Gu, D.S., Shambaugh, G.E., Metzger, B.E., and J.A. Radosevich.Circulating Growth Factors in the Fetus Alter Brain Cell Growth During Maternal Starvation. (American Federation of Clinical Research, Chicago, IL, 1990.)   
  87. Ng, Y.K., Radosevich, J.A., Bauer, K., and P.M. Iannaccone. Spatiotemperal Changes of p21 in Hepatocyte Cell Cycle during Liver Regeneration in Normal and Chimeric Rats. (American Society of Cell Biology, San Francisco, CA, 1990.)
  88. Haines, G.K., Ghadge, G., Thimmappaya, B., and J.A. Radosevich. Expression of the Protein Kinase P-68 Recognized by the Monoclonal Antibody TJ4C4 in Human Lung Neoplasms. (Presented at "An International Conference on Lung Cancer," Boston, 1990.)
  89. Radosevich, J.A., Rosen, S.T., and F.S. Siddiqui. The Human Adenocarcinoma Associated Antigen Recognized by the Monoclonal Antibody 44-3A6 is a Transmembrane phosphoprotein.(Presented at "An International Conference on Lung Cancer," Boston,1990.)
  90. Langman, C.B., Radosevich, J.A., Higbee, R.H., and J.M. Pensler. Isolation of Osteoclasts from Membranous Bone of Normal Children Exhibit Nuclear Estrogen and Progestrone Receptors. (3rd International Workshop On Cells and Cytokines In Bone and Cartilage, Davos, Switzerland, 1990.)
  91. Shambaugh, III, G.E., Gu, De Sheng, and J.A. Radosevich. Circulating Growth Factors in the Fetus Alter Brain Cell Growth During Maternal Starvation. (14th International Diabetes Federation Congress, Washington, D.C., 1991).
  92. Combs, S., Haines, G., Leslie, W., Thimmappaya, B., and J. Radosevich. Immunohisto-chemical Detection of eIF-2 Alpha Kinase with a Monoclonal Antibody TJ4C4 in AID associated Kaposi's Sarcoma.(International Academy of Pathology, Chicago, 1991.)
  93. Shambaugh, III, G.E., Unterman, T.G., Glick, R.A., Kelly, G.C., and J.A. Radosevich.Neonatal Rat Cerebellar Cells: A Model for study of Production and Regulation of IGF-II in the CNS. (2nd In ternational IGF Symposium, San Fransico, California, 1991.)
  94. Maker, V.K., Elseth, K.M., and J.A. Radosevich. Control of Local Recurrence of Breast Cancer Using the Contact Neodymium-Yttrium-Aluminum Garnett Laser. (American Society for Laser Medicine and Surgery, San Diego, California, 1991.)
  95. Gu, D.S., Shambaugh III, G.E., Metzger, B.E., and J.A. Radosevich. Do Circulating Growth Factors or Does Altered Cellular Response Play The Principal Role in Retardation of Fetal Brain Cell Growth During Maternal Starvation. (The Endocrine Society, Washington D.C., 1991).      
  96. Duda, R.B., August, C.Z., Nahrwold, D.L., and J.A. Radosevich. Monoclonal Antibody 44-3A6 As A Tumor Marker For Breast Cancer. (International Surgical Week, Stockholm, Sweden, 1991).
  97. Mittal, B.B., Zimmer, A.M., Sathiaseelan, V., Rosen, S.T., Radosevich, J.A., Rademaker, A.W., Pierce, M.C., Webber, D.I., Saini, A., and S.M. Spies. Effects of Hyperthermia and 131-I anti-CEA monclonal antibody on human colon carcinoma xenografts in nude mice. (Antibody Immunoconj. and Radiopharmaceuticals, 1991).
  98. Saini, A., Mittal, B.B., Zimmer, A.M., Sathiaseelan, V., Rosen, S.T., Radosevich, J.A., Rademaker, A.W., Pierce, M.C., Webber, D.I., and S.M. Spies. Hyperthermia induced enhancement of 131-I  radiolabeled monclonal antibodies in colon adenocarcinoma xenografts in nude mice. (Antibody Immunoconj. and Radiopharmaceuticals, 1991).
  99. Shambaugh, G.E., Gu, D., Unterman, T., B. Metzger, and J.A. Radosevich. Restoring IGF levels in fasted fetal serum enhances fetal brain cell growth. (American Federation of Clinical Research, Chicago, IL, 1991.)
  100. Shambaugh, G.E., Gu, D., Glick, R., Metzger, B., Radosevich, J. A., and T. Unterman. Can insulin-like growth factor-1 (IGF-I) and binding protein-1 (BP-1) modulate fetal brain cell growth during maternal starvation. (The Endorcrine Society, San Antonio, Texas,1992.)     
  101. Pensler, J.M., Ledesma, D.F., Hijjawi, J., Radosevich, J.A., and C.B. Langman.Plagiochephaly: Premature unilateral closure of the coronal suture: A localized disorder of cellular metabolism. (The Annual Meeting of ASPRS/PSEF/ASMA, Toronto, Ontario,1992.) 
  102. Hijjawi, J., Ledesma, D.F., Radosevich, J.A., and Pensler, J.M. Scaphochephaly—Early closure of the sagittal suture: A localized metabolic disorder. (The Annual Meeting of ASPRS/PSEF/ASMA, Toronto, Ontario, 1992.) 
  103. Szumel, R., Calujis, R.S., Hidvgi, D.F., and J.A. Radosevich. The monoclonal 44-3A6 as an adjunct in cytodiagnosis of adenocarcinoma in body fluids. (The Annual Meeting of the United States and Canadian Academy of Pathology, Atlanta, Georgia, 1992.)
  104. Haines, G.K., Ghadge, G., and J.A. Radosevich. Human fetal expression of the protein kinase (p68) using the monoclonal antibody TJ4C4. (American Federation of Clinical Research, Chicago, IL, 1992.)
  105. Kresl, J.J., Meyer, N.A., Potempa, L.A., Chi, C.W., Anderson, B., and J.A. Radosevich.In vivo evidence that a modified form of human c-reactive protein is an effective agent which suppresses the growth rate of  mouse mammary cell line EMT6 murine breast cancer. (American Federation of Clinical Research, Chicago, IL, 1992.)
  106. Cajulis, R.S., Hayden, R., Hidvegi, D.F., Duda, R.B., August, C.Z., and J.A. Radosevich.Monoclonal antibody TJ4C4 as a marker for breast neoplasms. (American Federation of Clinical Research, Chicago, IL, 1992.)
  107. Pensler, J.M., Ledesma, D.F., Hijjawi, J., Radosevich, J.A., and C.B. Langman.Plagiochephaly: Premature unilateral closure of the coronal suture: A localized disorder of cellular metabolism. (Plastic Surgical Forum: Vol. XV, Washington D.C., 1992).
  108. Radosevich, J.A., Bradley, G.S., and K.M. Elseth. Molecular cloning of the human nag gene which encodes the protein Labyrinthin: The adenocarcinoma tumor associated antigen detected by the monoclonal antibody 44-3A6. (Presented at the American Federation of Clinical Research, Chicago, IL, 1993.)
  109. Natarajan, N., Elseth, K.M., Shambaugh III, G.E., and J.A. Radosevich. A rapid assessment of cell number: Adaptation of the diphenylamine assay to a 96 well assay format and comparison with the metabolic MTT assay. (American Federation of Clinical Research, Chicago, IL, 1993.)
  110. Dubreuil, R.R., Souik, P., and J.A. Radosevich. Tumor associated epitopes detected by workshop antibodies react in similar clusters in Drosophila. (Third International IASLC Workshop on Lung Tumor and Differentiation Antigens, Zurich, Switzerland, 1993.)
  111. Radosevich, J.A., Bradley, G.S., and K.M. Elseth. Molecular cloning of the human nag gene: The adenocarcinoma tumor associated antigen (Labyrinthin) detected by the monoclonal antibody 44-3A6. (Third International IASLC Workshop on Lung Tumor and Differentiation Antigens, Zurich, Switzerland, 1993.)   
  112. Talamonti, M.S., Singh, C., Haines G.K., and J.A. Radosevich. Expression of  the protein kinase p68 recognized by the monoclonal antibody TJ4C4 in human colon cancer. (The Society of Surgical Oncology, Houston, Texas, 1994.)
  113. Gangopadhyay, A., Chavis, A., Thomas, P., Radosevich, J., and G.K. Haines.Characterization of monoclonal antibody AGB2 recognizing an antigen expressed both in canine mammary and human breast carcinomas. (American Association for Cancer Research, San Fransico, California, 1994.)   
  114. Haines, G.K., and J.A. Radosevich. P68 kinase as a new marker for differentiation in human upper aerodigestive tumors: Clinical and pathological correlations. (UICC XVI International Cancer Congress, New Delhi, India, 1994.)
  115. Radosevich, J.A., Bradley, G.S., and K.M. Elseth. Cloning of the human nag gene from a pulmonary adenocarcinoma cell line and expression of the tumor associated antigen (Labyrinthin) detected by the monoclonal antibody 44-3A6.(UICC XVI International Cancer Congress, New Delhi, India, 1994.)
  116. Shambaugh III, G., Natarajan, N., Radosevich, J., and T. Unterman. Nutritional insult in the neonatal cerebellum: Alterations in circulating and tissue levels of IGF-I and IGF binding proteins (IGFBPs). (The annual meeting of the Endocrine Society, Anaheim, California, 1994.)
  117. Shambaugh III, G., Natarajan, N., Radosevich, J.A., and M.L. Davenport. Neonatal caloric deficiency and recovery: Serum and tissue IGFs and their impact on cerebellar growth. (The Central Society For Clinical Research, Chicago, Illinois, 1994.)
  118. Haines G.K., Cajulis, R.S, Hayden, R.T., Duda, R.B., and J.A. Radosevich. Breast carcinoma is resistant to the antiproliferative and pro-differentiation effects of p68. (The Midwest American Federation For Clinical Research, Chicago, Illinois, 1994.)          
  119. Radosevich, J.A., Elseth, K.M., Bradley, G.S., and G.K. Haines. pH modulates the expression of Labyrinthin - The human adenocacinoma marker detected by the monoclonal antibody 44-3A6. (Presented at the Midwestern American Federation For Clinical Research, Chicago, Illinois, 1994.)
  120. Radosevich, J.A., Elseth, K.M., and G.S. Bradley. Molecular analysis of Labyrinthin: The cell surface adenocarcinoma marker recognized by the monoclonal antibody 44-3A6.(Presented at the International Symposium:Cancer Vaccines, New York, New York, 1994.)
  121. Haines, G.K., Zielinski, M., Brown, T., Panos, R.J., Leyland, J., Becker, S., Kies, M., Pelzer, H., and J.A. Radosevich. P68 and PCNA are inversely distributed in squamous cell carcinoma of the head and neck. (International Academy of Pathology Annual Meeting, Toronto, Canada, 1995.)
  122. Bentz, B.G., Haines, G.K., vonSchlegell, A.S., Elseth, K.M., Hanson, D.G., and J.A. Radosevich. Monoclonal antibody 44-3A6 localization of Labyrinthin in salivary gland neoplasia.(Midwestern American Federation For Clinical Research, Chicago, Illinois,1995.)
  123. Bentz, B.G., Haines III, G.K., Hanson, D.G., and J.A. Radosevich. Head and neck squamous cell carcinoma expresses a spectrum of constitutive nitric oxide synthase.(Fourth International Metting: Biology of nitric oxide, Amelia Island, Florida, 1995.)
  124. Radosevich, J.A., Bradley, G.S., and K.M. Elseth. Epitope mapping of the adenocarcinoma related monoclonal antibody 44-3A6 on Labyrinthin. (Presented at The XXIII Meeting of the International Society for Oncodevelopmental Biology and Medicine, 1995.)
  125. Barnes M.N., Bentz, B., Radosevich, J.A., Huang, C.F., Lurain, J.R., and G.K. Haines, III. Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in endometrial carcinoma. (National Meeting of SGO, 1995.)
  126. Bentz, B.G., Haines III, G.K., vonSchlegell A.S., Elseth, K.M., Hanson, D.G., and J.A. Radosevich. Labyrinthin expression in salivary gland neoplasia. (The American Laryngological, Rhinological and Otological Society Annual Meeting, Grand Cypress, Orlando, Florida, 1996.)Bentz, B.G., Haines III, G.K., Hanson, D.G., and J.A. Radosevich. Prognostic significance of constitutive nitric oxide synthase in salivary gland neoplasia.(4th International Conference on Head and Neck Cancer, Toronto, Canada, 1996.)
  127. Radosevich, J.A., Haines III, G.K., Motie, M., Crump, B.L., Schaul, K.W., Kolb, K., and L.A. Potempa. Immunohistochemical detection of epitopes expressed on CRP and modified-CRP (i.e.neo-CRP) in human normal and diseased tissues. (Presented at FASEB, New Orleans, Louisiana, 1996.) 
  128. Radosevich, J.A., Elseth, K.M., G.K. Haines, III. Labyrinthin expression is induced by serum starvation and heat shock in A549 cells. (Presented at the Midwest AFCR Meetings, Chicago, Illinois, 1996.)
  129. Haines III, G.K., Zielinski, M., Brown, T., Leyland, J., and J.A. Radosevich. Expression of topoisomerase II in squamous cell carcinoma of the head and neck. (Midwest AFCR Meetings, Chicago, Illinois, 1996.)
  130. Radosevich, J.A., Elseth, K.M., and G.K. Haines III. Heat shock and serum starvation induce Labyrinthin expression in A549 cells. (Presented at Cancer Vaccines 1996, New York, New York, 1996.)
  131. Radosevich, J.A., Elseth, K.M., and G.K. Haines, III. Anti-sense expression of Labyrinthin in A549 cells results in contact inhibition and reduced growth rate. (Presented at ISOBM-96, San Diego, California, 1996.)
  132. Potempa, L.A., Murphy, R., Radosevich, J.A., Anderson, B., Kresl, J.J, and B. Chan. Biological activity and clinical safety of human modified C-reactive protein, an active new agent against cancer. (Third Hong Kong International Cacner Congress and Seventh International EBV Symposium, Hong Kong, 1996.)
  133. Potempa, L.A., Motie, M., Murphy, R., Kabat, W., Yogev, R., Radosevich, J.A., Vaith,  P., and B. Chan. In vitro studies of recombinant human modified C reactive protein, an active new agent against HIV disease.(Hong Kong AIDS Conference, Hong Kong,1996.)
  134. Bentz, B.G., Barnes, M.N., Haines, G.K., Lurain, J.R., Hanson, D.G., and J.A. Radosevich. Constitutive Nitric oxide synthase is diffusely expressed in endometrial carcinomas. (AFCR Annual Meeting; Biomedicine '96, Washington, D.C., 1996.) 
  135. Bentz, B.G., Haines, G.K., vonSchlegell A.S., Elseth, K.M., Hanson, D.G., and J.A. Radosevich. Labyrinthin expression in salivary gland neoplasia. (Annual Meeting of the American Academy of Otolaryngology - Head and Neck Surgery Foundation,Washington, D.C., 1996.)
  136. Bellafiore, L., Sanderson, K., and J.A. Radosevich. Study on the Factors Affecting the Accuracy and Reproducibility of Gradient Formation for Preparative LC. (Prep ‘98,Washington, DC, 1998.)
  137. Diehl, E.E., Radosevich, J.A., Haines III, G.K., Yokoo, H., and L.A. Potempa. Studies of the Anti-Tumor Activity of a Modified Form of C-Reactive Protein. (XVII International Cancer Congress, Rio De Janeiro, Brazil, 1998.)
  138. Bentz, B.G., Haines III, G.K., Hanson, D.G., and J.A. Radosevich. Nitrotyosine Implicates  Nitric Oxide In Head and Neck Squamous Cell Carcinoma. ( XVII International Cancer Congress, Rio De Janeiro, Brazil, 1998.)
  139. Radosevich, J.A., Elseth, K.M., and G.K. Haines III. Pre-clinical Developments in the Design of an Anti-Adenocarcinoma Vaccine For Humans Based On the Expresion of Labyrinthin. ( Presented at the XVII International Cancer Congress, Rio De Janeiro, Brazil, 1998.)
  140. Bentz, B.G., Haines III, G.K., Hanson, D.G., and J.A. Radosevich. Nitrotyrosine as a Marker of the Pathophysiologic Function of Nitric Oxide in Head and Neck Squamous Cell Carcinoma. ( American Society For Head and Neck Surgery/COSM, Palm Beach, Florida, 1998.)
  141. Bentz, B.G., Haines III, G.K., Diehl, E.E., and J.A. Radosevich. Nitric Oxide In Head and Neck Squamous Cell Carcinoma. (Midwest AFMR, Chicago, Illinois, 1998).   
  142. Diehl, E.E., Radosevich, J.A., Haines III, G.K., Yokoo, H., and L.A. Potempa. Effects of the Modified Form of C-Reactive Protein On Human Tumor Cells. (Midwest AFMR, Chicago, Illinois, 1998).
  143. Bentz, B.G., Haines III, G.K., and J.A. Radosevich. Endothelial Constitutuive Nitric Oxide Synthase and Nitrotyrosine Co-localize in Squamous Cell Carcinoma of the Head and Neck. (Triological Society Combined Otolaryngogology Spring Meeting Program, Palm Springs, CA, 1999.)
  144. Bentz, B.G., Haines III, G.K., and J.A. Radosevich. Glutathione-S-Transferase pi expression Parallells Nitric Oxide In Head & Neck Squamous Cell Carcinoma.(Triological Society Combined Otolaryngogology Spring Meeting Program, Palm Springs, CA, 1999.)
  145. Bentz, B.G., Haines III, G.K., Robinson, A.M., Shah, P, and J.A. Radosevich. Nitric Oxide and Apoptosis in Head and Neck Squamous Cell Carcinomas. (5th International Conference On Head and Neck Cancer, San Francisco, 2000.)
  146. Bentz, B.G., Haines III, G.K., and J.A. Radosevich. Glutathione S-Transferase Pi Expression Parallels Nitric Oxide in Head and Neck Squamous Cell Carcinoma.(Midwestern Sectional Meeting of the Triological Society, Cincinnati, OH, 2000.)
  147. Chandra, R.K., Haines III, G.K., Bentz, B.G., Shah, P., and J.A. Radosevich. Expression of NOS 3 in Reflux-Induced Esophageal Lesions. (Oto. Head Neck Surg. 123:P103, 2000.)
  148. Chandra, R.K., Bentz, B.G., Haines III, G.K., Shah, P., Robinson, A.M., and J.A.Radosevich. Expression of Nitric Oxide Synthase Type 3 in Gastric Mucosa, Metaplasia, and Adenocarcinoma. ( Midwestern Region ASCR, Chicago, IL, 2001.)
  149. Bentz, B.G., Chandra, R., Haines III, G.K., Robinson, A. M., and J.A. Radosevich.Endogenous or Exogenous Nitric Oxide Exposure Causes DNA Damage in Cancer. (AFCR:Clinical Research 2001, Arlington, VA, 2001.)
  150. Bentz, B.G., Chandra, R., Haines III, G.K., Robinson, A.M., and J.A. Radosevich. The role Of Nitric Oxide in the Mutational Events Leading to Cancer Development. (Am. Soc. Clin.Onc. Annual Meeting, San Francisco, CA, 2001.) 
  151. Lee, S., Hoffman, B.M., Barrett, A.G.M., Haines III, G.K., and J.A. Radosevich. Uptake of Near-IR Absorbing/Emitting Porphyrazine (Tetraazaporphyrin) Macrocycles by Normal and Tumor Cell Lines. (Midwestern Section AFCR, Chicago, IL, 2002.)
  152. Chandra, R.K., Bentz, B.G., Wiet, R.J., Haines III, G.K., and J.A. Radosevich. Cyclin A Expression in Acoustic Neuromas. (American Academy of Otolaryngology-Head and Neck Surgery, San Diego, CA, 2002.)
  153. Keni, S.P., Vakkalanka, S.K., Haines III, G.K., Radosevich, J.A., and K.W. Altman. Nitric Oxide Synthase Type 3 Expression is Increased in Dysplastic Laryngeal Squamous Papillomas. (The Annual Conference of the American Academy of Otolaryngology – Head & Neck Surgery, San Diego, CA, 2002.)
  154. Altman, K.W., Vakkalanka, S.K., Keni, S.J., Haines III, G.K., and J.A. Radosevich.Thyroid Hormone Receptor Expression in the Mouse Larynx. . (The Annual Conference of the American Academy of Otolaryngology – Head & Neck Surgery, San Diego, CA, 2002.)
  155. Bentz, B.G., Chandra, R., Haines III, G.K., and J.A. Radosevich. Endogenous or Exogenous Nitric Oxide Exprosure Causes DNA Damage in Cancer. (The Sixth Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer, Pittsburgh, PA, 2002.)
  156. Radosevich, J.A., Bentz, B., and G.K. Haines III. Labyrithin is a Mutated Form of Junctin/Junctate Associated With the Human Adenocarcinoma Phenotype. (Presented at: The XXXth meeting of the International Society For Oncodevelopmental Biology and Medicine, Boston, MA, 2002.)
  157. Hammer, N.D., Lee, S., Hoffman, B.M., and J.A. Radosevich. Structural Correlation of the Porphyrazines to Biological Activity. (American Federation for Medical Research, Chicago, IL, 2004.)
  158. Hammer, N.D., Haines III, G. K., Altman, K., Bentz, B.G., Elseth, K., and J.A.Radosevich.Transcriptional Analysis of the Human Aspartyl (asparaginyl) Beta-Hydroxylase Loci in Tumor Cells and Identification of Labyrinthin, a Tumor Specific Transcript. (ISOBM 2004, Helsinki, Finland, 2004).
  159. Hammer, N.D., Vesper, B.J., Lee, S., Zong, H , Hoffman, B. M.,and J.A. Radosevich.Structure-Function Correlations of Porphyrazines With Cell Killing. . (ISOBM 2004, Helsinki, Finland, 2004).
  160. Radosevich, J.A., Hammer, N.D., Elseth, K., Hewitt, S. M., Babich, M., Bentz, B.G, and G.K. Haines III. Expression of Calcium Ion Channel Components In Human Tumors. (Presented at ISOBM 2004, Helsinki, Finland, 2004).
  161. Babich, M., Radosevich, J.A., Hammer, N.D., Elseth, K., Hewitt, S.M.,  Bentz B.G., and GK Haines III. Selective Over Expression of Calcium Ion Channel Proteins In Human Tumors. (10th Annual Cancer Research Symposium, UC Davis Cancer Center, Sacramento, CA, 2005).
  162. Altman, K.W., Waltonen, J., Haines III G.K., Hammer ND, and J.A. Radosevich. Proton Pump Expression in Human Laryngeal Seromucinous Glands. (Middle Section of the Triological Society, Chicago, IL,    2005).
  163. Vesper B., Hammer N., Elseth K., Lee S., Barrett A., Hoffman B., and J.A. Radosevich. Porphyrazine Structure-Function Relationships: Effect of Peripheral Acid Groups on Cellular Toxicity. (2005 Clinic and  Research Day, Chicago, IL, 2005).
  164. Vesper B., Hammer N, Elseth K., Lee S., Barrett A., Hoffman B., and J.A. Radosevich. Changes in Peripheral Methoxy Groups On Porphyrazines Affect Their Cellular Toxicity. (2005 Clinic and  Research Day, Chicago, IL, 2005).
  165. Tarjan S., Hammer N., Vesper B., Elseth K., Hewitt S., Babich M., Bentz B., Haines III G.K., and J.A.  Radosevich. Overexpression of Calcium Ion Channel Components in Human Tumors. (2005 Clinic and Research Day, Chicago, IL, 2005).
  166. Elseth K., Hammer N., Vesper B., Bentz B., Haines III G.K., Roeske J., Mundt A., and J.A. Radosevich.  Nitric Oxide Synthatase and GST-pi Expression Correlates with Radiosensitivity in Human Oral Cancers. (2005 Clinic and Research Day, Chicago, IL, 2005).
  167. Waltonen J., Altman K., Haines III G.K., Bentz B., Hammer N., Tarjan S., Elseth S., and J.A. Radosevich.  Over Expression of Glutathione-S-Transferase-pi (GST-pi) Does Not Parallel Over Expression of Endothelial Constitutive Nitric Oxide Synthase (ecNOS) in Human Squamous Cell Laryngeal Tumors.  (2005 Clinic and  Research Day, Chicago, IL, 2005).
  168. Waltonen J., Haines III G.K., Radosevich, J. A., Bentz B., and K.W. Altman. Evidence of Oxidative Injury In The Human Laryngeal Squamous Papillomas. (Annual Meeting of the American Academy of  Otolaryngology – Head and Neck Surgery, Los Angeles, CA, 2005.)
  169. Waltonen J., Haines III G.K., Radosevich, J. A., Bentz B., and K.W. Altman.  Glutathione-S-Transferase  (GST-pi) is Over –Expressed in Radiation-resistant Human Squamous Cell Laryngeal Tumors. (American Head and Neck Meeting, Boca Raton, FL 2005).
  170. Vesper, B. J., Hammer, N.D., Bentz, B.G., Haines, G.K., and J.A. Radosevich. Predicting Radiosensitivity: Correlation of Nitric Oxide Synthatase and GST-pi Expression in Human Oral Cancers. (ISOBM 2005,  Rhodes, Greece 2005).
  171. Radosevich, J.A., Waltonen, J.D., Altman, K.W., Bentz, B.G., and G.K. Haines. Glutathione-S-Transferase-pi (GST-pi) is Over-Exprssed in Radiation-Resistant Human Squamous Cell Laryngeal Tumors. (Presented at the ISOBM, 20005, Rhodes, Greece. 2005)
  172. Vesper, B.J., Hammer, N.D., Lee, S., Elseth, K., Hoffman, B.M., and J.A. Radosevich. Porphyrazine Structure-Function Relationships: Effects of Core Metal and Number of Peripheral Acid Groups on  Biological Behavior. (ISOBM 2005, Rhodes, Greece 2005).
  173. Vesper, B.J., Hammer, N.D., Lee, S., Elseth, K., Hoffman, B.M., and J.A. Radosevich.  Charge Dependence of Cellular Uptake and Selective Anti-Tumor Activity of Porphyrazines. (ISOBM 2005,  Rhodes, Greece 2005).
  174. Altman, M., Chura, S., Smith, B., Vesper, B., Radosevich, J., and J. Roeske. A Noval Phantom For Use In 3- Dimensional In Vitro Cell Experiments. (American Association of Physicists in Medicine 48th Annual Meeting, Orlando, FL, 2006).
  175. J.A. Radosevich. Three Examples of Translational Research At UIC College of Dentistry. (Clinic & Research Day, Chicago, IL 2006).
  176. Mariscal, J.M., Vesper, B.J., and J.A. Radosevich. Spectral Imaging of Tissue Using Fiber Optics. (Clinic &   Research Day, Chicago, IL 2006).
  177. Vesper, B.J., Zong, H., Hammer, N.D., Elseth, K., Barrett, A.G.M., Hoffman, B.M., and J.A. Radosevich. Targeting Tumor Cell Receptors for Cancer Treatment: Estrogen-Functionalized Porphyrazines. (Clinic & Research Day, Chicago, IL 2006).
  178. Elseth, K., Bentz, B.G., Haines III, G.K., Altmen, K.W., and J.A. Radosevich. Nitric Oxide Can Inhibit Apoptosis in the Face of Ongoing Mutational Events by Altering Apoptosis-Related Gene Expression.  (Clinic &R esearch Day, Chicago, IL 2006).
  179. Khurram, H., Vesper, B.J., Elseth, K., Bentz, B.G., Haines, G.K., Gill, P., Tarjan, G., and J. A. Radosevich. Expression of Inducible Nitric Oxide Synthase (iNOS) in Human Cervical Cancer. (Clinic & Research Day, Chicago, IL 2006).
  180. Khurram, H., Gill, P., Elseth, K., Tarjan, G., Bentz, B., Altman, K., Haines III, G.K., and J.A. Radosevich. Endothelial Constitutive Nitric Oxide Synthatase (ecNOS) and Inducible Nitric Oxide Synthatase (iNOS) Are Inversely Over Expressed in Tumors of the Tongue. (Clinic & Research Day, Chicago, IL 2006).
  181. Elseth, K., Bentz. B.G., Vesper, B.J., Haines III, G.K., Altman, K.W., and J.A. Radosevich. Long-Term Nitric Oxide Treated Human Tumor and Normal Cell Lines. (Clinic & Research Day, Chicago, IL 2006).
  182. Vesper, B.J., Hammer, N.D., Elseth, K., Lee, S., Barrett, A.G.M., Hoffman, B.M., and J.A. Radosevich. Preparation and Study of Acid-Functionalized Porphyrazines in the Treatment of Head and Neck Cancers. (Clinic & Research Day, Chicago, IL 2006).
  183. Chhaya, V., Hammer, N.D., Pavlova, S., Elseth, K., Vesper, B.J., Altman, K.W., Tao, L., and J.A.  Radosevich. Drug Toxicity and Adverse Side Effects of Proton Pump Inhibitors: Efect of PPI on Gastrointestinal Flora. (Clinic & Research Day, Chicago, IL 2006).
  184. Radosevich, J.A. and M. Babich. From The Gene Discovery of Labyrinthin To The Translational Application of An Adenocarcinoma Vaccine. (Presented at the 2006 International Conference: Frontiers of Pharmacology  and Toxicology, Chicago, IL 2006).
  185. Altman, K.W., Waltonen, J.D., Tarjan, G., Radosevich, J.A., and G.K. Haines.  Human Lung Mucus Glands Manifest Evidence Of The H+/K+-ATPase Proton Pump. (86th Annual Meeting of The American  BronchoEsophagological Association, Chicago, IL. 2006).
  186. Gill, P.S., Khurram, H., Tarjan, G., Haines, G.K., and J.A. Radosevich. Overexpression of Nitric Oxide. Synthase Isoforms (ecNOS and iNOS) In Squamous Cell Carcinoma of the Tongue. (2006 USCAP Annual Meeting, Atlanta, GA , 2006).
  187. Chhaya, V., Hammer, N., Pavlova, S. Elseth, K., Vesper, B.J., Altman, K.W., Tao, L., and J.A. Radosevich. Drug Toxicity and Adverse Side Effects in Gastroesophageal Reflux Disease (GERD): Effect of Proton Pump Inhibitors (PPIs) on Gatrointestinal Flora. (Chicago Area Undergraduate Research Symposium, Chicago, IL, 2006).  
  188. Elseth, K., Bentz, B.G., Vesper, B.J., Yao, M., Haines, G.K., Altman, K., and J.A. Radosevich. Tumor Cells Adapt More Quickly to Hight Levels of Nitric Oxide than Normal Cell Lines and Become More Malignant in a High Nitric Oxide Environment. (American Head & Neck Society Annual Meeting,  Chicago, IL, 2006).
  189. Khurram, H., Vepser, B.J., Elseth, K., Targan, G., Bentz, B., Altman, K., Haines, G.K., and J.A.  Radosevich. Nitric Oxide Synthase Expression in  Squamous Cell Carcinoma  of the Tongue. (Sigma Xi  Science Graduate Research Forum, Chicago, IL, 2006).
  190. Vesper, B., Hammer, N.D., Lee, S., Elseth, K., Barrett, A.G.M., Hoffman, B.M., and J.A. Radosevich. Acid-Functionalized Porphyrines Exhibit Anti-Tumor Behavior in Head and Neck Squamous Cell Carcinomas. (The 4th Chinese Conference of Oncology, Tainjin , China, 2006).
  191. Radosevich, J.A., Vesper, B.J., Elseth, K., Bentz, B.G., Altman, K.W., and G.K. Haines. Nitric Oxide  Inhibits Apoptosis-Related Gene Expression Via S-Nitrosylation In a Caspase-9 Dependent Fashion. (Presented at The 4th Chinese Conference of Oncology, Tainjin , China, 2006).
  192. Altman, K., Vesper, B., Tao, L., Hammer, N., Chhaya, V., and J.A. Radosevich. Proton Pump Expression by Oral Cavity Bacteria. (110th Annual meeting of the Triological Society, San Diego, CA, 2007).
  193. Khurram, H., Vepser, B.J., Elseth, K., Targan, G., Bentz, B., Altman, K., Haines, G.K., and J.A. Radosevich. Over-Expression of  Inducible Nitric Oxide Synthathase (iNOS) in Human Cervical Carcinoma. (96th Annual  Meeting United States and Canadian Academy of Pathology, San Diego, 2007.)
  194. Yarmolyuk, Y.R., Elseth, K., Vesper, B.J., Haines, G.K., Bentz, B.G., and J.A. Radosevich. Understanding  the Effects of Nitric Oxide on Tumor Formation and Progression. (Clinic & Research Day 2007, Chicago, IL 2007.)
  195. Vesper, B.J., Lee, S., Zong, H., Hammer, N.D., Elseth, K., Barrett, A.G.M., Hoffman, B.M., and J.A. Radosevich. The Isoindolines Are a New Class of Imaging and Therapeutic Agents For the Detection and Treatment of Cancer. (Clinic & Research Day 2007, Chicago, IL 2007.)
  196. Vesper, B.J., Altman, M.B., Elseth, K., Roeske, J., and J.A. Radosevich. Development of a Novel Intensity-Modulated Radiation Therapy (IMRT) Phantom to Mimic Patient Exposure During Radiation Treatment. (Clinic & Research Day 2007, Chicago, IL 2007.)
  197. Elseth, K., Vesper, B.J., Lee, S., Zong, H., Hammer, N.D., Barrett, A.G. M., Hoffman, B.M., and J.A. Radosevich. Structure-Function Studies of Porphyrazine Anti-Tumor Agents: New Class of Compounds Found to Exhibit Light-Enhanced Toxicity. (Clinic & Research Day 2007, Chicago, IL 2007.)  
  198. Chhaya, V., Hammer, N.D., Pavlova, S., Elseth, K., Vesper, B.J., Altman, K.W., Tao, L., and J.A.  Radosevich. The Effects of Proton Pump Inhibitors On the Bacterial FRlora of Gastroesophageal Reflux Disease (GERD) Patients. (Presented at the 5th Joint Meeting on Medical Chemistry, Portoroz, Slovenia, 2007.)
  199. Radosevich, J.A., Yarmolyuk, Y.R., Elseth, K.M., Vesper, B.J., Haines, III, G. K., and Bentz, B.. Understanding the Role Nitric Oxide Plays in Tumor Formation and Progression.  (Presented at the 14th  European Cancer Conference, Barcelona, Spain, 2007)
  200. Vesper, B.J., Lee, S., Zong, H., Hammer, N.D., Elseth, K., Barrett, A.G.M., Hoffman, B.M., and J.A. Radosevich. Tumor Uptake and Photo-Enhanced Toxicity of Thiotriethoxy(ethoxy)methyl-Functionalized Porphyrazines. (14th  European Cancer Conference, Barcelona, Spain, 2007)
  201. Vesper, B.J., Altman, M.B., Elseth, K.M., Roeske, J.C., Haines III, G.K., Altman, K.W., Bentz, B.G., and J.A. Radosevich. Can Nitric Oxide Be Used as a Predictor of Radiation Response? ( 1st International Conference on Nitric Oxide and Cancer, Paris France, 2007.)
  202. Radosevich, J.A., Vesper, B.J., Elseth, K.M., Haines III, G.K., Altman, K.W., and B.G. Bentz. Comparing the Ability of Normal and Tumor Cells to Adapt to High Levels of Nitric Oxide. (Presented at the 1st International Conference on Nitric Oxide and Cancer, Paris France, 2007.)
  203. Elseth, K.M., Vesper, B.J., Schwartz, J.L., Bentz, B., Haines III, G.K., and J.A. Radosevich. The Ability of  Nitric Oxide to Induce Carcinogenesis in Normal Cells. (Clinic & Research Day 2008, Chicago, IL, 2008.)
  204. Khurram, H., Elseth, K.M., Vesper, B.J., Targan, G., Bentz, B., Haines III, G.K., and J.A. Radosevich. Over-Expresion of Nitric Oxide Synthase (NOS), Glutathione S-Transferase (GST-pi), and Apurinic/Apyrimidinic Endonuclease (APE-1) in Tumors of the Tongue. (Clinic & Research Day 2008, Chicago, IL, 2008.)
  205. Vesper, B.J., Altman, M.B., Elseth, K.M., Roeske, J.C., and J.A. Radosevich. Predicting Patient Response to Radiation: In Vitro Cell Culture Studies Using an Intensity-Modulated Therapy (IMRT) Head & Neck Phantom. (Clinic & Research Day 2008, Chicago, IL, 2008.)
  206. MacDonald, C.C., Elseth, K.M., Vesper, B.J., Bentz, B.G., Haines III, G.K., Altman, K.W., Tarjan, G. and J.A. Radosevich. Apurinic/Apyrimidinic Endonuclease (APE-1) and Nitric Oxide Synthase Are Up-regulated in Human Laryngeal Cancer. (Clinic & Research Day 2008, Chicago, IL, 2008.)
  207. Defranco, C., Schwartz, J., Alayyoubi, M., Zhou, C., Radosevich, J.A., and P. Gettins. Maspin: A new Tumor  Suppressor Protein for Oral Carcinogenesis and Tumorigenesis. (Clinic & Research Day 2008, Chicago, IL,  2008.)
  208. Radosevich, J.A., Yarmolyuk, Y.R., Vesper, B.J., Khurram, H., Tarjan, G., and G.K. Haines III. Development  of a Human Tumor Tissue Culture System that Mimics Nitric Oxide Synthase Expression of Tumors Arising  in the Tongue. (Presented at the 36th ISOBM annual meeting, Tokyo, Japan, 2008).
  209. Radosevich, J.A., Vesper, B., Waltonen, J., Elseth, K., Tarjan, G., Altman, K., Bentz, B., and G. K. Haines. Understanding the Role of Nitric Oxide and Related Gene Products in Human Tumors: An In Vitro Model the  Mimics Clinical Observations.  (2nd International Workshop- Training Course On Molecular Medicine and Drug Research,  Karachi, Pakistan, 2009.)
  210. Elseth, K., Vesper, B.J., Haines III, G.K., Tarjan, G., and J.A. Radosevich. Aggressive Growth Behavior of Human Oral Squamous Cell Lines Adapted to Nitric Oxide-Enriched Environments. (Clinic & Research Day 2009, Chicago, IL, 2009.)
  211. Aparajita, R., Elseth, K., Vesper, B.J., Haines III, G.K., Tarjan, G., Kolokythas, A., J.A. Radosevich. Expression of Argininosuccinate Synthetase (ASS) and Argininosuccinate (ASL) in Human Oral Squamous  Cell Carcinoma. (Clinic & Research Day 2009, Chicago, IL, 2009.)
  212. Vesper, B.J., Altman, M.B., Elseth, K.M., Haines III, G.K., Tarjan, G., Roeske, J.C., Bulent, A., and J.A. Radosevich. Ultraviolet (UV) and X-ray Radiation Resistance of Oral Squamous Carcinoma Cell Lines Adapted to Long-Term Nitric Oxide (NO) Exposure. (Clinic & Research Day 2009, Chicago, IL, 2009.)
  213. Vesper, B.J., Trivedi, E.R., Zong, H., Lee, S., Hoffman, B.M., and J.A. Radosevich. A New Subclass of Porphyrazines Anti-Tumor Agents: Structure-Function Studies of Oxygen-Appended Porphyazines. (Clinic & Research Day 2009, Chicago, IL, 2009.)
  214. Sroussi, H. Y., Lu, Y., Villines, D., Radosevich, J.A., and P.T. Marucha.  S100A8 and S100A8 Inhibit  Peripheral Neutrophil Oxidative Metabolism in a PKC Theta Dependent Pathway. (Clinic & Research Day 2009, Chicago, IL, 2009.)
  215. Aparajita, R., Elseth, K., Vesper, B.J., Haines III, G.K., Tarjan, G., Kolokythas, A., J.A. Radosevich. Human  Oral Tumors and Expression of Argininosuccinate Synthetase (ASS) and Argininosuccinate Lyase (ASL).  (International Academy of Oral Oncology, Toronto, Canada, 2009).
  216. Yarmolyuk, Y.R., Elseth, K., Vesper, B.J., Haines III, G.K., Tarjan, G., and J.A. Radosevich. Aggressive Behavior of Tumors Adapted to High Nitric Oxide Environments. ( 2009 Midwestern Regional Dental Student  Research Conference, Chicago, IL, 2009.)
  217. Yarmolyuk, Y.R., Elseth, K., Vesper, B.J., Haines III, G.K., Tarjan, G., and J.A. Radosevich. Adaptation of Head And Neck Squamous Carcinoma Cells to a Nitric Oxide Environment Leads to More Aggressive Growth. (2009 UIC Student Research Forum, Chicago, IL, 2009.)
  218. Radosevich, J.A., Tarjan, G., Elseth, K.M., Paradise, W.A., Vesper, B.J., Goel, A., and G.K. Haines III. Development of a Novel Model System to Discover New Biomarkers Based On Nitric Oxide Induced Gene  Expression. (Presented at the 37th Annual ISOBM Meeting, Amsterdam, Netherlands, 2009)
  219. Onul, A. Elseth, K., Verpser, B.J., Haines III, G.K., Tarjan, G., Goel, A., and J.A. Radosevich.  Effects of Different Free Radical Donores on a Human Lung Cell Line Adapted to High Nitric Oxide (HNO) Levels.  (Clinic & Research Day 2019, Chicago, IL, 2010.)
  220. Elseth, K., Onul, A., Vesper B.J., Haines, G.K., Tarjan, G., Goel, A., and J.A. Radosevich. Temperature  Resistance in High Nitric Oxide-Adapted Lung Adenocarcinoma Cells. (Clinic & Research Day 2019, Chicago, IL, 2010.)
  221. Malik, G., Elseth, K., Vesper, B.J., Haines III, G.K., Tarjan, G., Goel, A., and James A. Radosevich. Elevated Expression of HIF-1 (alpha) in High Nitric Oxide-Adapted Human lung Tumor Cells. (Clinic & Research Day 2019, Chicago, IL, 2010.)
  222. Vesper, B.E., Song, Y., Zong, H., Trivedi, E.R., Waters, A., Barrett, A.G.M., Hoffman, B.M., Meade, T.J., and James A. Radosevich. Preparation and Characterization of Porphyrazine-Based Magnetic Resonance Imaging Contrast Agents. (Clinic & Research Day 2019, Chicago, IL, 2010.)
  223. Paradise, W.A., Vesper, B.J., Altman, M.B., Elseth, K.M., Haines III, G.K., Tarjan, G., Roeske, J.C., Aydogan, B., and J. A. Radosevich. Gamma Radiation and Ultraviolet Resistance of a Breast Cancer Cell Line Adapted to Long-Term Nitric Oxide Exposure. (Clinic & Research Day 2010, Chicago, IL, 2010.)
  224. Rubinstein, P., Lindgren, V., Setty, S., Yao, M., Pytynia, K.B., Radosevich, J.A., Kadkol, S.S., and L.E. Feldman. Durable Complete Remission Induced by Cetuximab Monotherapy in an HIV Infected Patient With Recurrent Squamous Cell Carcinoma of the Head and Neck. ( ASCO, Chicago, IL, 2010.)
  225. Radosevich, J.A., Vesper, B.J., Paradise, W.A., Elseth, K.M., Xue, J., Haines III. G.K., Tarjan, G., and A.  Goel. A Human Lung Tumor Cell Line Exposed to Long-Term High Nitric Oxide Levels Exhibits Tumor  Stem Cell-Like Properties.  (Presented at the 11th International Lung Cancer congress, Los Angeles, USA,  2010).
  226. Radosevich, J.A., Vesper, B.J., Paradise, B., Elseth, K., Xue, J., Targan, G., and G.K. Haines III Development of a Human Tumor Tissue Culture System That Mimics Nitric Oxide Synthase Expression in Human Tumors. (Presented at BIT3rd Annual World Cancer Congress -2010, Singapore, 2010).
  227. Radosevich, J.A., Vesper, B.J., Onul, A., Paradise, W.A., Elseth, K.M., Xue, J., Haines III, G.K., Tarjan, G.,and A. Goel. The Role of Nitric Oxide in Human Lung Cancer: A Model System Based on a Cell Line Exposed to Long-term Nitric Oxide. (Presented at 38th ISOBM, Munich, Germany, 2010).
  228. Vesper, B.J., Tarjan, G., Haines III, G.K., Xue, J., Elseth, K.. M., Paradise, W.A., Aydogan, B., and J.A. Radosevich.  Understanding How Nitric Oxide Levels in the Cellular Microenvironment Affect Tumor Aggressiveness in Squamous Cell Carcinomas. (9th International Congress on Targeted Therapies in Cancer, Washington, D.C., 2010)
  229. Kavak, G,  Yeginer, M.,  Radosevich, J.A. and B. Aydrogan.  How many Arc is Enough? A Dosimetric Comparison of RapidArc VMAT and Fixed Gantry IMRT for High-Risk Prostate Cancer. (Clinic & Research Day 2011, Chicago, IL, 2011.).
  230. Ivanova, S.A., Onul, A., Elseth, K., Amegashie, C.P., Vesper, B.J., Gouvas, E., Haines III, G.K., Tarjan, G., Goel, A., and J. A. Radosevich.  Are High Nitric Oxide-Adapted Tumor 3Cells More Resistant to pH Manipulation? (Clinic & Research Day 2011, Chicago, IL, 2011.).
  231. Elseth, K.M., Vesper, B.J.,  Gouvas, E.,  Onul, A., Xue, J., Paradise, W.A.,  Haines III, G.K., Tarjan, G., Goel, A., and  J. A. Radosevich.    Do Tumor Cells Adapted Long-Term to Nitric Oxide Exhibit Enhanced Tumor Stem Cell-Like Properties? (Clinic & Research Day 2011, Chicago, IL, 2011.).
  232. Platt, F.J., Elseth, K.M., Onul, A., Vesper, B.J., Haines III, G.K., Aydogan, B., Tarjan, G., and J. A. Radosevich. Elevated Hypoxia-Inducible Factor (HIF-1α) Expression in Human Tongue Carcinoma Cell Lines Adapted to Long-Term Nitric Oxide Exposure. (Clinic & Research Day 2011, Chicago, IL, 2011.).
  233. Gouvas, E., Vesper, B.J., Tarjan, G., Haines III, G.K., Xue, J., Elseth, K.M., Paradise, W.A., Aydogan, B. and J. A. Radosevich. Effects of High Nitric Oxide Levels on Tumor Behavior in Tongue Squamous Cell  Carcinomas. (Clinic & Research Day 2011, Chicago, IL, 2011.).
  234. Amegashie, C.P., Gouvas, E., Ivanova, S.A., Vesper, B.J.,  Elseth, K.M.,  Tarjan, G., Haines III, G.K., and J. A. Radosevich. Effect of High Nitric Oxide Microenvironments on Oral Cancer Cell Migration. (Clinic & Research Day 2011, Chicago, IL, 2011.).
  235. Glick, C.M., Vesper, B.J., Wilkie, J.R, Onul, A., Kavak, G.O., Aydogan, B., and J. A. Radosevich. Effect of  Daily Dose Variation in Radiation Treatment of Human Breast Tumors. (Clinic & Research Day 2011,  Chicago, IL, 2011.).
  236. Paradise, W.A., Onul, A., Gouvas, E., Vesper, B.J., Elseth, K.M., Xue, J., Garcia, K.D., Colvard, M.D. and
    237. J. A. Radosevich. Comparative Evaluation of Staining Techniques for the Detection of Tissue Damage in> Wounds. (Clinic & Research Day 2011, Chicago, IL, 2011.).
  237. Xue, J., Elseth, K.M., Onul, A., Vesper,  B.J., Tarjan, G., Haines III, G.K.,  and J. A. Radosevich. Analysis of High Nitric Oxide Tolerance in A549 Cells: A Biological Conundrum? (Clinic & Research Day 2011, Chicago, IL, 2011.).
  238. Onul, A., Elseth, K. M., Vesper, B.J, Haines III, G.K., Tarjan, G., and J. A. Radosevich. Long-Term Adaptation of a Human Lung Tumor to an Oxygen-Based Free Radical Donor. (Clinic & Research Day 2011, Chicago, IL, 2011.).
  239. Altman, K.W., Kinoshita, Y., Tan-Geller, M., Burstein, D., and J.A. Radosevich. Western Blot Confirmation of the H+/K+-ATPase proton Pump in the Human Larynx and Submandibular Gland. (Annual Meeting of the American Laryngological Association, Chicago, IL, 2011).
  240. Ivanova, S.A., Onul, A., Elseth, K.M., Vesper, B., and J.A. Radosevich. Are High Nitric Oxide Producing Tumor Cells More Resistant to pH Change Than Low Producing Tumor Cells. (The Student Research Forum, Chicago, IL, 2011.
  241. Radosevich, J.A., Onul, A., Gouvas, E., Elseth, K., Vesper, B.J., Paradise, W., Haines III, G.K., De Vetto, H., Rumjanek, F.D., and G. Tarjan. The Role of Nitric Oxide In Human Tumors – Changing The Way We Treat Patients. (Presented at the 8th International Scientific Conference, Astrakhan Medical Academy, Astrakhan, Russia, 2011.)
  242. Aurisano, J., Radosevich, J.A., and J Leigh. Toward System-Level Visualizations of Molecular Networks on Large-Scale, High Resolution. (BioVis 2011, Providence, RI, 2011).
  243. J.A. Radosevich. Improved Immunohistochemical Method For The Visualization Of Tissue Damage Caused By Laser Exposure. (Presented at the 2011 AFMS Medical Research Symposium, National Harbor, M.D., 2011.)    
  244. De Vitto, H., Mendonca, B.S., Elseth, K.M., Onul, A., Noweder, A., Xue, J., Vesper, B.J., Gallo, C.V.M., Rumjanek, F.D., and J.A. Radosevich. Characterization of Human Breast Tumor Cell Lines BT-20 Adapted to Long-Term High Nitric Oxide Exposure. (39th ISOBM, Florence, Italy, 2011).
  245. De Vitto, H., Mendonca, B.S., Elseth, K.M., Onul, A., Vesper, B.J., Portari, E.A., Gallo, C.V.M.,  Radosevich, J.A., and F.D. Rumjanek. Assessment of Mitochondrial DNA Damage in Human Breast  Cancer. (39th ISOBM, Florence, Italy, 2011).  
  246. Gouvas, E., Amegashie, C., Elseth, K.M., Vesper, B.J., Haines III, G.K., Tarjan, G., and J.A. Radosevich. Nitric Oxide Modulates HIF-1 alpha Expression in Human Lung Cancer. (39th ISOBM, Florence, Italy, 2011).
  247. Radosevich, J.A., Elseth, K.M., and B.J. Vesper. The case for a New Tumor Stem Cell Theory: “Tumor Cell Plasticity.” (Present at 39th ISOBM, Florence, Italy, 2011).
  248. Onul, A., Elseth, K.M., Gouvas, E., Ivanova, S.A., Vesper, B.J., Aydogan, B., and J.A. Radosevich. Expression of “Croass-Tolerance to a Wide Range of Conditions in a Human Lung Cancer Cell line After  Adaptation to Nitric Oxide. (39th ISOBM, Florence, Italy, 2011).
  249. Onul, A., De Vitto, H., Elseth, K.M., Vesper, B.J., Deliu, Z., Rumjanek, F.D., and J.A. Radosevich.  Adaptation of a Human Lung Tumor to an Oxygen-Based Free Radical Donor. (39th ISOBM, Florence,  Italy, 2010).
  250. Gouvas, E., Vesper, B.J., Tarjan, G., Haines III, G.K., Elseth, K.M., Aydogan, B., and J.A. Radosevich. Daily Dose Variation of Radiation Effects on Human Breast Tumors.  (39th ISOBM, Florence, Italy, 2011).
  251. Noweder, A., Platt, F., Onul, A., Bassiony, M., Vesper, B.J., Miresmaili, S., and J.A. Radosevich. Cytotoxicity of Cinnamon Oil On Human Cancer Cells. (Clinic & Research Day 2011, Chicago, IL, 2012).
  252. Gouvas, E., Onul, A., Elseth, K.M., Deliu, Z., Ivanova, S.A., Noweder, A., Amegashie, C., Vesper, B., Paradise, W.A., Garcia, K.D., Colvard, M.D., and J.A. Radosevich. Laser Induced Tissue Damage From A Newly Developed Hand-Held Thulium Laser. (Clinic & Research Day 2011, Chicago, IL, 2012).
  253. Sarigul, N., Radosevich, J., Koshy, M., Kavak, G., Ozturk, N., Smith,, B., Yeginer, M., Awan, A., Surueu,  M., Patel, P., Rondelli, R., Welchselbaum, R., and B. Aydogen. (Clinic & Research Day 2011, Chicago, IL, 2012).
  254. Elseth, K., Vesper, B.J., Sweet, M., and J.A. Radosevich. Evidence Supporting a New Tumor Stem Cell Theory. (Clinic & Research Day 2011, Chicago, IL, 2012).
  255. Huang, J., Kim, M., Elseth, K.M., Vesper, B.J., Bassiony, M., Aydrogan, B., And J.A. Radosevich. Development of an Improved Soft Agar Method.  (Clinic & Research Day 2011, Chicago, IL, 2012).
  256. Paradise, W.A., Onul, A., Gouvas, E., Vesper, B.J., Elseth, K.M., Garcia, K.D., Colvard, M.D., and J.A. Radosevich. Comparative Evaluation of Staining Techniques for the Detection of Tissue Damage Induced by Directed Energy Devices (DEDs). (Clinic & Research Day 2011, Chicago, IL, 2012).
  257. Ivanova, S.A., Onul, A., Elseth, K.M., Vesper, B.J., Gouvas, E., Haines III, G.K., Tarjan, G., and J.A. Radosevich. Human Breast Cancer Cells Adapted To An Oxygen Based Free Radical Environment Are More Resistant To pH and Calcium Maniplulation. (Clinic & Research Day 2011, Chicago, IL, 2012).
  258. Deliu, Z., Onul, A., Elseth, K.M., Gouvas, E. Ivanova, S.I., Vesper, B.J., Noweder, A., Sweet, M., Aydogan, B., and J.A. Radosevich. Development of a Cell Line Model System Exhibiting  “Cross-Tolerance” to Diverse Environmental Stressors. (Clinic & Research Day 2011, Chicago, IL, 2012).
  259. Onul, A., Elseth, K., Vesper, B.J., Haines III, G.K., Paradise, W.A., Gouvas, E., Tarjan, G., and J.A. Radosevich. Long-Term Adaptation of Human Tumor Cell Lines To An Oxygen-based Free Radical Donor. (Clinic & Research Day 2011, Chicago, IL, 2012).
  260. Bassiony, M., Yang, J., Tawfeek, A-M., Elmogy, S. Elnagdy, M., and J.A. Radosevich. Ultrasonogaphy As Diagnostic Tool In Staging of Maxillofacial Infections of Dental Origin. (Clinic & Research Day 2012,  Chicago, IL, 2012).
  261. Amegashi, C.P., Gouvas, E., Ivanova, S. A., Vesper, B.J., Elseth, K.M., Targan, G., Haines III, G.K., and James A. Radosevich. Concentration Effect of Chemically Induced Hypoxia On The Metastasis of High Nitric Oxide Adapted and Non-Adapted Cancer Cells. (Clinic & Research Day 2011, Chicago, IL, 2012).
  262. Elseth, K., Vesper, B.J., Sweet, M., and J.A. Radosevich. A New Tumor Stem Cell Theory – Data Toward Validation. (UIC Cancer Center Research Forum 2011, Chicago, IL, 2012).
  263. Radosevich, J.A., Elseth, K., Vesper, B.J., Javadov, R., and M. Sweet. Evidence supporting A New Tumor Stem Cell Plasticity Theory. (Presented at the 1st Symposium on Head & Neck Cancer Stem Cells, Ann  Arbor, MI, 2012).
  264. Amegashie, C.P., Elseth, K.M., Vesper, B.J., Targan, G., Haines III, G.K., and J.A. Radosevich. The Comparison of Motility in Parent Versus High Nitric Oxide Adapted Cells. (Illinois Mathematics and Science Academy 2012, Aurora, IL, 2012).
  265. Radosevich, J.A., Elseth, K.M., Paradise, W.A., Deliu, Z., Desai, P.B., Thanki, D.H., Aqil, M., and M. Bassiony. Nitric Oxide Exposure Results In Cross Tolerance. (Presented at the 40th Annual ISOBM Meeting, Jerusalem, Israel, 2012).
  266. Radosevich, J.A., Murphy, B. T., Wei, X., Elseth, K.M., Paradise, W.A., Aqil, M., and M. Bassiony. Tumor Stem Cells: Do They Really Exist? (Presented at the 40th Annual ISOBM Meeting, Jerusalem, Israel, 2012).
  267. Aqil, M., Elseth, K.M., Wei, X., Murphy, B.T., and J. A. Radosevich. Marine Microbial Secondary Metabolites As Chemical Probes To Identify Novel Drug Targets In Lung Tumor Stem Cells. (26th Annual Clinic and Research Day 2013, Chicago, IL, 2013).
  268. Elseth, K.M., Vesper, B.J., Deliu, Z., Onul, A., Bassiony, M., Aqil, M., and J.A. Radosevich. Antioxidant Effects of Equol and NaRLA on a Human Lung Cancer Cell Line Adapted to High Nitric Oxide. (26th Annual Clinic and Research Day 2013, Chicago, IL, 2013).
  269. Verma, R., Kim, K., Elseth, K.M., Aqil, M., De Vitto, H., and J. A. Radosevich. Hydrogen Peroxide Production In High Nitric Oxide Adapted Human Lung Cancer Cells Which Express Tumor Stem Cell “Like” Properties. (26th Annual Clinic and Research Day 2013, Chicago, IL, 2013).
  270. Bassiony, M.A., Vesper, B.J., Colvard, M.D., Elseth, K.M., Garcia, K.D., Leigh, J., Mateevitsi, V.A., and J.A. Radosevich.  A 3D Digital Evaluation of Lateral Tissue Damage of Incisional Wounds Treated With The Biolase iLase Laser. (26th Annual Clinic and Research Day 2013, Chicago, IL, 2013).
  271. Delui, Z., Elseth, K.M., Aqil, M., Onul, A., De Vitto, H., and J.A. Radosevich. High Hydrogen Peroxide (HHP) Adapted Human Tumor Cells Are Prone To Grow Anaerobically. (26th Annual Clinic and Research Day 2013, Chicago, IL, 2013).
  272. Desai, P.B., Thanki, D.H., Elseth, K.M., Aqil, M., and J.A. Radosevich. Effect of High Nitric Oxide On Lung Carcinoma Cell Adhesion. (26th Annual Clinic and Research Day 2013, Chicago, IL, 2013).
  273. Kim, K., Verma, R., Elseth, K., Aqil, M., and J.A. Radosevich. Hydrogen Peroxide Production In High Nitric Oxide Adapted Human Cancer Cells Which Express Tumor Stem Cell – Like Properties. (25th IMSALoquium, Aurora, IL, 2013).
  274. Budyn, E., Bhogle, S., Lacey, S., Radosevich, J.A., and M. Colvard. Thermal Identification During The  Cauterization Process In Porcine Skin. (USNCCM, Raleigh, N.C., 2013).
  275. Budyn, E., Bhogle, S., Lacey, S., Radosevich, J.A., and M. Colvard. Thermal Microenvironment of  Keratinocytes and Fibroblasts During Cauterization. (Bioengineering, Sunriver, OR., 2013).
  276. Radosevich, J.A., Elseth, K., Aqil, M., Dudek, A.Z., and L. Feldman. Supporting Evidence For A New Tumor  Stem Cell Plasticity Model Based On Adaptation To Nitric Oxide. (Presented at 15th Annual Meeting IASLC, Sydney, Australia, 2013).
  277. Dudek, A.Z., Aqil, M., Elseth, K.M., Feldman, L., Tarjan, G., and J.A. Radosevich. Nitric Oxide Adapted Lung Tumor Cells Express Tumor Stem Cell-Like Markers. (15th Annual Meeting IASLC, Sydney, Australia, 2013).
  278. Vesper, B.J., Mateevitsi, V.A., Elseth, K.M., Bassiony, M.A., Colvard, M.D., Garcia, K.D., Leigh, J., and J.A. Radosevich. Evaluation of Laser-Treated Tissue With A High Throughput 3-D Imaging Method.  (Presented at Pathology Visions 2012, San Antonio, TX, 2013).
  279. Budyn, E., Bhogle, S., Radosevich, J.A., and M.D. Colvard. Thermal Microenvironment of Keatinocytes and Fifroblasts during Cauterixation by Laser Devices. (3rd International Conference on Computational and Mathematical Biomedical Engineering  [CMBE 2013] Nithiaruasu P and R Lohner  [Eds.], Hong Kong, 2013).
  280. Elseth, K., Radosevich, J.A., Aqil, M., Dudek, A., and L. Feldman. Supporting evidence For A New Tumor  Stem Cell Plasticity Model Based on Adaptation to Nitric Oxide. (J. Thoracic Oncology, 8:S1042-S1042; 2013).
  281. Aqil, M., Elseth, K.M., Kolonda, J., and J.A. Radosevich. HNOS Adapted A549 Cells Show Reduced Surface CEACAM Expression And Enhanced Migration. (27th Annual Clinic and Research Day 2014, Chicago, IL, 2014).
  282. Arjunakani, A., Nebres, P., Aqil, M., Elseth, K., and J.A. Radosevich. The Effect of Nitric Oxide On Cellular Adhesion For Various Cancer Cell Lines. (27th Annual Clinic and Research Day 2014, Chicago,  IL, 2014).
  283. Bassiony, M.A., Vesper, B.J., Mateevitisi, V.A., Elseth, K.M., Colvard, M.D., Garcia, K.D., Leigh, J., and J.A. Radosevich. Immunohistochemical Evaluation of Bleeding Control Induced By Holmium Laser and Biolase Dental Laser As Coagulating Devices of Incisional Wounds. (27th Annual Clinic and Research Day 2014, Chicago, IL, 2014).
  284. Elseth, K., Amegashie, C., Aqil, M., Tarjan, G., and J.A. Radosevich. Adaptation To Nitric Oxide Exposure Leads To Resistance to Hypoxia In A549 Lung Cancer Cells. (27th Annual Clinic and Research Day 2014, Chicago, IL, 2014).
  285. Kolonda, J., Elseth, K.M., Aqil, M., Amegashie, C.P., and J.A. Radosevich. Metastatic Properties Of High Nitric Oxide Cells vs Parent Cells. (27th Annual Clinic and Research Day 2014, Chicago, IL, 2014).
  286. Dixon- Rojas, M., Elseth, K., Aqil, M., Bassiony, M., Sayres, J., Vesper, B., and J.A. Radosevich. Lipoclain 2 (LCN2) Is Consistently Up-Regulated In Head & Neck Cancer Cell lines Adapted To High Nitric Oxide (HNO) Levels. (27th Annual Clinic and Research Day 2014, Chicago, IL, 2014).
  287. Sayres, J., Aqil, M., Deliu, Z., Onul, A. Elseth, K.M., Aydogan, B., and J.A. Radosevich. Development of A Human Lung Cancer Model System Exhibiting “Cross – Tolerance” to Diverse Environmental Factors. (27th Annual Clinic and Research Day 2014, Chicago, IL, 2014).
  288. Song, Q., Aqil, M., Elseth, K.M., and J.A. Radosevich. Role of CA2+ Regulatory Proteins STIM1 And ORAI 1In A High Nitric Oxide Adapted Stem – Like Human Lung Adenocarcinoma Cells.  (27th Annual Clinic and Research Day 2014, Chicago, IL, 2014).
  289. Song, Q., Aqil, M., Elseth, K.M., and J.A. Radosevich. Increased STIM1 and ORAI1 Expression May Contribute to the Apoptotic Resistance of the High Nitric Oxide (HNO) Adapted Human Lung Adenocarcino A549 Cells. (UIC-Cancer Research Forum 2014, Chicago, IL 2014).
  290. Radosevich, J.A., Kuganeswaran, R., Luna, C., Deliu, Z., Hamed, D., Aqil, M.m Al Oweidi, A., Khalili, M., M. Bassiony .The Role of Nitric Oxide in Human Tumor Stem Cell Development: A New Theory About Tumor Stem Cells and New Drugs to Kill Them. (National Conference on Pure and Applied Chemistry, Mysore, India, 2014).
  291. Deliu, Z., Dixon-Rojas, M., Elseth, K, Aqil, M., Bassiony, M., Vesper, B., and J.A. Radosevich. Head & Neck Cell Lines Adapted to High Nitric Oxide (HNO) Levels Consistently Up-Regulate Lipocalin 2 (LCN2). (9th International Conference of Anticancer Research, Potro Carras, Sithonia, Greece, 2014).
  292. Radosevich, J.A., Murphy, Brian, T., Wei, X., Elsesth, K.M., Deliu, Z., Aqil, M., and M. Bassiony. A New Way to Think About Tumor Stem Cells.  (9th International Conference of Anticancer Research, Potro  Carras, Sithonia, Greece, 2014).
  293. Radosevich, J.A., Dixon-Rojas, M., Elseth, K., Aqil, M., Bassiony, M., and B. Vesper. Lipocalin 2 (LCN2)  is Consistently Up-Regulated in Head and Neck High Nitric Oxide Adapter Cells Which Exhibit Tumor Stem Cell Properties. (41st Congress ISOBM, Barcelona, 2014).
  294. Dixon – Rojas, M., Elseth, K., Aqil, M., Bassiony, M., Sayres, J., Vesper, B., J.A. Radosevich. Adaptation to High Nitric Oxide (HNO) in Head and Neck Cancer cell Lines Consistantly Up-Regulated Lipocalin 2  (LCN2) (UIC Cancer Forum, Chicago, 2014).
  295. Luna, C., Zick, A., Alwidi, A., Hamed, D., Dixon – Rojas, M., Aqil, M., Bassiony, M., and J.A. Radosevich. Genomic Mutational Analysis of High Nirtic Oxide Adapted Human Lung Adenocarcinoma Cells Compared to Parent Cells. (28th Annual Clinic and Research Day 2015, Chicago, IL, 2015).
  296. Al Oweidi, A., Kuganeswaran, R., Luna, C., Deliu, Z., Hamed, D., Aqil, M., Khalili, M., and J.A. Radosevich. Exposure to Nitric Oxide Causes Over- Expression of SOX2 and SOX21 Genes in A549 Lung Cancer Cells. (28th Annual Clinic and Research Day 2015, Chicago, IL, 2015).

Patents:

  1. Radosevich, James A. and S.L. Barclay.  Construction of a Simple Apparatus Which Produces Multiple Identical Gradients Simultaneously.  (Patent 1983, #S.N. 6,903,879.)
  2. Rosen, S.T., Ma, Y., and J.A. Radosevich.  A Monoclonal Antibody 44-3A6 Which Reacts With A Cell Surface Component On Human Adenocarcinoma Of The Lung.  (Patent 1985, #S.N. 4,816,402.)
  3. Radosevich, James A., Rosen, S.T., and Y. Ma. Murine Hybridoma and Diagnostic Antibody Produced Thereby (MCA 44-3A6). (Patent 1992,  #1,295,271 Canadian).
  4. Radosevich, James A. A Gene Encoding A Marker For Adenocarcinomas (Patents Applied For/Granted in over 75 countries; 1998.).
  5. Potempa, Lawrence A., Diehl, Edward E., and James A. Radosevich. Use of mCRP Delivery of Materials Into Cells (Patent 1998; #60/097,128).
  6. Radosevich, James A. and Lawrence A. Potempa. Use of mCRP to Slow Cell Growth And To Promote Maturation Of Cells (Patent 1998; #60/097,280).
  7. Radosevich, James A. and Lawrence A Potempa. Use of mCRP  to Enhance Immune Responses (Patent 2001; #6,280,743).
  8. Radosevich, James A. Cancer Marker Protein and Peptides Thereof (Patent 2000; #6,166,176).
  9. Radosevich, James A. Compositions and Methods for Treating Adenocarcinomas (Patent filed March 22, 2010).
  10. Radosevich, James A. Humanized Antibodies to Labyrinthin and Uses Thereof (Patent filed March 15, 2010).
  11. Bellafiore, L., Glicken, E. and James A. Radosevich. Tocotrienol Compositions (Patent filed May 26, 2010).
  12. Radosevich, James A. Production of Tumor Stem Cells with Free Radicals. (Patent filed May 22, 2010).

Review Boards:

  1. Marcel Dekker, Inc.; Editor-At-Large, Hematology/Oncology; February, 1989 - 1995. 
  2. Chicago Lung Association; Grant Review Board Member, 1992.
  3. Ad Hoc Special Review Committee - NCI/NIH; Grant Review Board Member, 1992.
  4. Ad Hoc Special Review Committee - NCI/NIH; Grant Review Board Member, 1997.
  5. Tumor Biology, Reviewer, 1988 – Present.  
  6. Journal of Clinical pathology, Reviewer, 1995 – Present. 
  7. Chest, Reviewer, 1990 – Present.
  8. Nutrition and Cancer: An International Journal, Reviewer, 2008 –Present.
  9. International Scholarly Research Network – Pulmonology, 2011 –Present.
  10. Free Radicals and Antioxidants, 2010 – Present.

Special presentations:

  1. "Experimental and Human Lung Carcinogenesis," at the 14th International Cancer Congress, Budapest, Hungary, 1986.
  2. "Non-Small Cell Lung Cancer Antigens," at the Satellite Symposium On Lung Cancer  Antigens (Fifth World  Conference On Lung Cancer), Interlaken, Switzerland, 1988.
  3. "Immunological Aspects of Lung Cancer," at the Third Annual Malnati Symposium, Chicago, Illinois, 1992.
  4. “Development of an Anti-Adenocarcinoma Peptide Vaccine” at The Chinese University of Hong Kong, Hong Kong, 1999.
  5. “Peptide Cancer Vaccine Development” at the Zhong Guan Cun Conference, Beijing,  People’s Republic of China, 2000. 
  6. “Applications in Biodontics” at the Frontiers In Scientific Health Annual Study Club Meeting, Athabasca, Canada, 2005.
  7. “Nitric Oxide Inhibits Apoptosis-Related Gene Expression Via S-Nitrosylation In a Caspase-9 Dependent Fashion,” at The 4th Chinese Conference of Oncology, Tainjin , China, 2006).
  8. “The Role of Nitric Oxide In Human Tumors – Changing The Way We Treat Patients,” The 8th Annual International Scientific Conference, Astrakhan Medical Academy, Astrakhan, Russia.
  9. Bradley University Graduate College Commencement (Commencement Address), Peoria, Illinois, 2011.
  10. “How our Understanding of Nitric Oxide Expression in Huma Tumors is Changing the Way We Think about Treating Patients,” Istanbul Medeniyet University, Istanbul, Turkey, 2013.
  11. “The Role of Nitric Oxide In Human Tumors,” National Center of Oncology, Baku, Azerbaijan, 2013.
  12. Valedictory Closing Remarks, National Conference on Pure and Applied Chemistry, University of Mysore, Mysore, India, 2014.
Manuscripts in Preparation:
  1. Radosevich, J.A., Elseth, K.M., and G.S. Bradley. Molecular cloning of the human Labyrinthin gene (Manuscript in preparation.)
  2. Radosevich, J.A., Elseth, K.M., and G.S. Bradley. Plasma membrane topology of the human adenocarcinoma associated antigen (Labyrinthin).  (Manuscript in  preparation.)
  3. Radosevich, J.A., Elseth, K.M., and G.S. Bradley. Molecular epitope mapping of the anti-adenocarcinoma monoclonal antibody 44-3A6 on the human Labyrinthin  gene product. (Manuscript in preparation.)
  4. Radosevich, J.A., Elseth, K.M., and G.S. Bradley. Labyrinthin expression is modulated by extracellular pH. (Manuscript in preparation.)
  5. Radosevich, J.A., Elseth, K.M., and G.S. Bradley. Expression of auto-antibodies by patients with adenocarcinomas to the Labyrinthin gene product. (Manuscript in preparation.)
  6. Barnes, M.N, Bentz, B., Huang, C.-F., Radosevich, J.A., Lurain, J.R., and G.K. Haines. Correlation of the  expression of double-stranded RNA - dependent protein kinase  (p68) with differentiation in endometrial adenocarcinoma. J. Gynecology and Obstetrics. (Submitted: Tumor Biology).
  7. Chandra, R.K., Bentz, B.G., Wiet, R.J., Haines III, G.K., and J.A. Radosevich. Cyclin A Expression in Acoustic Neurons. (Submitted: Otolaryngology –Head & Neck Surgery).
  8. Bentz, B.G., Haines III, G.K., Bak, P.M., and J.A. Radosevich. Co-Localization of Nitrotyrosine and Nitric Oxide In Head and Neck Squamous Cell Carcinoma. (Submitted: Cancer Letters).
  9. Altman, K.W., Keni, S.P., Vakkalanka, S.K., Haines, G.K. III, and J.A.Radosevich. “Nitric Oxide Synthase Type 3 Expression is Increased in Dysplastic Laryngeal Squamous Papillomas,” (Submitted).
  10. Altman, K.W., Vakkalanka, S.K., Keni, S.P., Haines, G.K. III, and J.A.Radosevich., “Thyroid Hormone Receptor expression in the Rodent Larynx,” (Submitted).
  11. Waltonen, J.D., Altman, K.W., Bentz, B.G., Radosevich, J.A., and G.K. Haines III. “Evidence of Oxidative Injury in Human Laryngeal Squamous Papillomas,” (Submitted).
  12. Waltonen, J.D., Altman, K.W., Bentz, B.G., Radosevich, J.A., and G.K. Haines III. “Glutathione-S-Transferase-pi (GST-pi) is Over-Expressed in Radiation-resistant Human Squamous Cell Laryngeal Tumors,”(Submitted).
  13. Bentz, G.B., Hammer, N.D., Milash, B., Burnett, D.M., Radosevich, J.A., and G.K. Haines. Short Term Nitric Oxide Exposure Alters Apoptosis-Related Gene Expression Contributing To Nitrosative Stress Resistance (Submitted).
  14. Vesper, B.J., Lee, S., Hammer, N.D., Elseth, K.M., Zong, H., Barrett, A.G.M., Hoffman, B.H., and J.A. Radosevich, “Effect of Substituent Charge and Length on the Biocompatibility of Isoindolines.” ChemMedChem (Submitted).
  15. Zong, H., Vesper, B.J., Elseth, K.M., Barrett, A.G.M., Hoffman, B.M., and J.A. Radosevich. “Targeting Breast Cancer: Preparation and Cellular Toxicity Studies of Estrogen-Functionalized Porphyrazines.” Manuscript in Preparation.
  16. Lee, S., Vesper, B.J., Zong, H., Hammer, N.D., Elseth, K.M., Barrett, A.G.M., Hoffman, B.M., and J.A. Radosevich. “Synthesis and Biological Analysis of Thiotetra(ethylene glycol) monomethyl  ether-Functionalized Porphyrazines: Cellular Uptake and Toxicity Studies.” Metal Based Drugs, (Submitted).
  17. Vesper, B.J., Khurram, H., Elseth, K.M., Bentz, B.G., Haines, III, G.K., Gill, P., Tarjan, G., and J.A.Radosevich.  “Over-Expression of Inducible Nitric Oxide Synthase (iNOS) and Glutathione S-Transferase-pi (GST-pi) in Human Cervical Cancer.” Manuscript in Preparation.
  18. Vesper, B.J., Khurram, H., Elseth, K.M., Bentz, B.G., Haines, III, G.K., Tarjan, G., and J.A.  Radosevich. “Nitric Oxide Synthase Expression in Human Tongue Carcinomas.” Manuscript in Preparation.
  19. Vesper, B.J., Elseth, K.M., Bentz, B.G., Haines, III, G.K., Altman, K.W., and J.A. Radosevich. “The Ongoing  Development of a Murine Lung Model to Mimic Lung Cancer Progression: Introduction of High Levels of Nitric Oxide to a Tumor Cell Line.” Manuscript in Preparation.
  20. Vesper, B.J., Altman, M.B., Elseth, K.M., Roeske, J.C., and J.A. Radosevich, J.A. “Radiation Response of Human Oral Squamous Cell Carcinoma Cell Lines Adapted to Nitric Oxide.” Manuscript in Preparation.
  21. Vesper, B.J., Khurram, H., Elseth, K.M., Bentz, B.G., Haines III, G.K., Targan,G., and J.A. Radosevich.  Nitric Oxide Synthase and Glutathione S- Transerase Expression in Human Cervical Cancer.  Pathology Internatational  (Submitted).

 

 

 

 

James A. Radosevich

Professor of Molecular Biology of Oral Diseases

 

  • : 312-996-9538
  • : 312-996-9592
  • DEPARTMENT College of Dentistry
    University of Illinois at Chicago
  • COUNTRYUSA